Aug 2017

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.


PO BOX 106 954, AUCKLAND CITY 1143<br />

Email: info@nzoptics.co.nz Website: www.nzoptics.co.nz<br />

AUGUST <strong>2017</strong><br />

A Brilliant New LeNs<br />






<strong>2017</strong><br />



SOON!<br />






Half-day session on OCT best<br />

practice usage and routines<br />

covering diabetes, glaucoma and<br />

age-related maculopathy in three<br />

one-hour sessions.<br />



Peter Larsen<br />

Optometry Director, Specsavers<br />

Australia & New Zealand<br />

Host and Facilitator<br />

Prof Robyn Guymer<br />

Deputy Director, Centre for Eye<br />

Research Australia<br />

Age-related macular degeneration in<br />

the new era of classification imaging<br />

and management<br />

Dr Simon Chen<br />

Retinal & Cataract Surgeon,<br />

Vision Eye Institute<br />

Clinical pearls for managing diabetic<br />

retinopathy in optometric practice<br />

Dr Mitchell Lawlor<br />

Glaucoma Surgeon &<br />

Neuro-ophthalmologist,<br />

Sydney Eye Hospital<br />

Update on the collaboration between<br />

ophthalmology and optometry<br />

Assoc Prof Mark Daniell<br />

President, RANZCO<br />

Corneal disease: latest research<br />

and treatment<br />

Assoc Prof Angus Turner<br />

Associate Professor, Lions Eye Institute<br />

The integration of emerging technologies<br />

in optometric practice<br />

Dr Carl Glittenberg<br />

Senior Clinical Advisor, Topcon Medical<br />

The evolution of imaging technology to aid<br />

diagnosis in an optometric environment<br />

Dr Peter van Wijngaarden<br />

Deputy Director & Principal<br />

Investigator, Centre for Eye<br />

Research Australia<br />

Diabetic retinopathy: diagnosis,<br />

management and recent advances<br />

For full details on the SCC ticket, flights and accommodation prize draw, CPD/CD points and to register your place,<br />

contact Madeleine Curran on +61 (0)401 100 772 or madeleine.curran@specsavers.com<br />


2 NEW ZEALAND OPTICS <strong>Aug</strong>ust <strong>2017</strong>

The brilliance of ‘Brilliant’<br />

Maui Jim’s most advanced<br />

sunglass lens to date, and<br />

the most advanced nonglass<br />

lens when it comes to clarity<br />

ever to be unveiled, hit New Zealand<br />

this month.<br />

The new Maui Brilliant lens defies<br />

convention, combining clarity<br />

similar to glass with glass’ scratch<br />

resistance, but just one-third the<br />

weight of glass with the high<br />

impact resistance of traditional<br />

polycarbonate. According to the<br />

company, Maui Jim’s “revolutionary”<br />

new, proprietary lens material,<br />

“MauiBrilliant”, offers almost twice the clarity of traditional lenses<br />

together with Maui Jim’s PolarizedPlus2 technology, which the<br />

company is famous for.<br />

“Maui Jim is constantly evolving its lens offering,” says Nathan<br />

Fisher, director of marketing for Maui Jim Asia, Pacific and Middle<br />

East. “The development of the proprietary Maui Brilliant lens is the<br />

pinnacle of lens design and technology and continues to cement<br />

Maui Jim as the world’s most technologically advanced sunglass<br />

brand.”<br />

Understanding the optics<br />

Maui Jim’s Koko Head sunnies, now available in MauiBrilliant Rx<br />

Clarity is measured in Abbe values – the dispersion of light in<br />

a transparent material. The Abbe number (VD) of a material<br />

is defined as: VD = nD-1/ nF- nc, where nD, nF and nC are the<br />

refractive indices of the material at the wavelengths of the<br />

spectral lines.<br />

Higher Abbe values indicate better optical clarity, with perfect<br />

transparency equalling 100. The Abbe value of the eye is around<br />

45 to 50. Lenses with lower Abbe values produce chromatic<br />

aberration, which increases at higher lens powers. This failure to<br />

focus all colours to the same convergence point is seen as coloured<br />

fringes at the border of an image and some people are far more<br />

susceptible to this aberration than others. Maui Jim has always<br />

prided itself on designing lenses that are as optically correct as<br />

possible to limit distortion and enhance colour.<br />

When choosing sunglass lens materials, consumers often have<br />

to compromise either in clarity, weight or scratch resistance.<br />

Glass lenses offer high levels of clarity and scratch resistance, but<br />

at the expense of weight and impact resistance. Standard 1.50<br />

index glass lenses have excellent clarity with an Abbe value of 59.<br />

Traditional polycarbonate lenses have a much lower Abbe value<br />

of 30, less-effective scratch resistance, but are lightweight and<br />

impact-resistant. Maui Brilliant is a mid-index, non-glass lens, but<br />

the company has achieved an incredible Abbe value of 56 plus high<br />

impact resistance.<br />

Maui Brilliant is also the lightest<br />

lens material for use in the optical<br />

industry, explains the company. At<br />

1.00 specific gravity, Maui Brilliant<br />

is 61% lighter than glass and 16%<br />

lighter than polycarbonate, and will<br />

almost float on water, making it the<br />

lightest, highest-clarity prescriptionready<br />

lens available in the world<br />

today.<br />

For the patient<br />

“Maui Brilliant will benefit wearers<br />

who spend long periods of time in<br />

the sun where heavier glass lenses may become uncomfortable<br />

and cause strain or eye fatigue. It’s ideal for men and women who<br />

enjoy an active lifestyle and is highly attractive for prescription<br />

sunglass wearers,” says Fisher. “All Maui Jim sunglasses also<br />

feature the patented, PolarisedPlus2 technology, which blocks<br />

100% of ultra violet rays, eliminates 99.9% of glare and manages<br />

95% of high-energy visible light.” Like polycarbonate lenses, Maui<br />

Brilliant lenses are produced using an injection moulding process,<br />

so thickness can be better controlled, and the polarised film is<br />

very consistent in its location, 0.6mm from the front of the lens,<br />

making them superior to cast lenses, he adds.<br />

So how does Maui Brilliant break the rules and combine all these<br />

desirable lens attributes into one product? Fisher says his lips are<br />

sealed. “We can’t reveal the secrets behind the creation of this lens<br />

technology, but we can say we think Maui Brilliant will become<br />

the superstar of non-glass lens materials.<br />

The company also offers its “Maui Passport difference” on Maui<br />

Brilliant lenses, where it makes every prescription lens using its<br />

own exclusive digital lens design and cutting-edge direct surfacing<br />

technology, he says. “This approach delivers the widest possible<br />

field of view, so you can see clear, colourful detail across the<br />

entirety of each lens. Our process produces prescriptions that are<br />

10 times more accurate than standard labs and maintains the<br />

highest optical and quality standards in the industry.”<br />

Maui Brilliant is available from 1 <strong>Aug</strong>ust in both single vision<br />

and progressive prescriptions (combined power +3.00DS to<br />

-6.50DS) across its entire range of more than 120 sunglasses<br />

styles. It’s also unrestricted by frame and lens combinations<br />

(unlike polycarbonate which may react with<br />

acetate frames) and<br />

is also available in<br />

an ever-expanding<br />

range of plano styles,<br />

says Fisher. ▀<br />

Maui Jim’s Koko Head<br />

sunnies, now available<br />

in MauiBrilliant Rx<br />

Too much going on?<br />


Is it just me, or does the eye world seem to be going so fast at the<br />

moment, it feels a bit like a roundabout that’s out of control.<br />

Practically every exhibitor at ODMA17 had some big piece of news:<br />

a new gizmo, a new app, a new way of doing business. Many driven<br />

by opportunity as independents look for alternatives to Essilor as its<br />

merger with Luxottica looms. The giant twosome filed their application<br />

with our Commerce Commission in July. We’ve got all the news from<br />

ODMA dotted throughout this issue as well as in our special feature on<br />

p12-17, and there’s more to come next month.<br />

Talking of next month, the dry eye space is veritably exploding with<br />

news. We’ve held this back to next month for our popular, annual dry<br />

eye special feature, peer-reviewed by the international dry eye queen<br />

herself, our own, A/Prof Jennifer Craig. Staying with the ophthalmic<br />

world, the fight for control of the increasingly lucrative wet AMD<br />

space is hotting up with Novartis pitting its latest anti-VEGF offering<br />

directly against Bayer’s Eylea (p21). We’ve got more on AMD, and the<br />

government’s and optometry’s changing roles in this on p7 and p21, as<br />

eye health practitioners battle to stem the tide despite a rapidly-aging<br />

population.<br />

In other news, Maui Jim has finally launched its technically-brilliant<br />

‘Brilliant’ lens to the market (this page) and we cover the end, for<br />

now, of NZ’s ODMA, Visionz, after 35 years (p7). The saddest news of<br />

all, however, was the death of Gordon Sanderson. The anecdotes and<br />

memories you shared on our Facebook page about what an incredible<br />

man he was were a joy to read. Thank you.<br />

In some ways<br />

paying tribute<br />

to Gordon’s<br />

wonderful sense<br />

of humour<br />

(depicted<br />

beautifully by his<br />

friend Dr Philip<br />

Polkinghorne on<br />

p20), for a lighter<br />

look at the eye<br />

health world,<br />

we’re delighted to<br />

introduce a new<br />

columnist,<br />

the well-known<br />

raconteur and author,<br />

David Slack on our popular<br />

Chalkeye’s page. Enjoy!<br />

Yours truly with Hoya’s Krista Hoey, Stuart Whelan and Teresa Sepede<br />

at ODMA17<br />

Lesley Springall, publisher, NZ Optics<br />

SHOW<br />

silmoparis.com<br />

www.littlepeach.co.nz<br />

office@littlepeach.co.nz<br />

0800 573 224<br />

<strong>Aug</strong>ust <strong>2017</strong><br />



News<br />

in brief<br />


Indiana-based Purdue University<br />

start-up, BioNode has developed<br />

a wearable, neuro-modulation<br />

device as a non-invasive therapy<br />

for glaucoma. BioNode’s<br />

technology features a standard<br />

contact lens with a gold trace<br />

which can transmit an electric<br />

current, triggered by a speciallyequipped<br />

pair of glasses, to stimulate the Schlemm canal muscles<br />

to decrease pressure, said Professor Pedro Irazoqui, BioNode’s<br />

co-founder. “There’s no surgery, it’s not invasive. It takes about five<br />

minutes and has no known side effects.” The startup is seeking<br />

US$1.5 million for a 100-patient clinical trial.<br />


Essilor and Luxottica have applied to the Commerce Commission<br />

to make their worldwide 46 billion euro merger a reality in New<br />

Zealand. The Commission highlighted Essilor’s wholesale supply<br />

of finished prescription lenses and its online store Clearly.co.nz,<br />

and Luxottica’s wholesale supply of frames and sunglasses, and<br />

retail operations via its OPSM, Sunglass Hut and Oakley stores. “We<br />

will give clearance to a proposed merger only if we are satisfied<br />

the merger is unlikely to have the effect of substantially lessening<br />

competition in a market,” it said.<br />


A research team has successfully used magnets to treat nystagmus.<br />

The study by University College London and Oxford University<br />

researchers, and published in Ophthalmology, used an oculomotor<br />

prosthesis to control eye movement. “While the exact neural<br />

mechanisms causing nystagmus are still not fully understood,<br />

we have shown it can still be corrected with a prosthesis, without<br />

needing to address the neural cause,” said study co-leader, Professor<br />

Christopher Kennard.<br />

Joining the Eyepro gang<br />

In the wake of the estimated 46<br />

billion euro Essilor-Luxottica merger,<br />

independent optometry network<br />

Eyepro is adding new partnerships and<br />

stepping up activities to support existing<br />

and encourage new members.<br />

Eyepro was founded nearly 15 years<br />

ago by Chris Clark, who also runs Curtis<br />

Vision and Misty Optic (distributor of<br />

Charmant and Spy eyewear), as a support<br />

network for independent optometrists<br />

who wanted to remain independent. It<br />

now has close to 60 members. But with<br />

Clark’s increasing workload, Eyepro was<br />

restructured “and reinvigorated” earlier<br />

this year, with the appointment of Misty<br />

Optic’s Tom Frowde as general manager,<br />

he says. “It was just fortuitous that the<br />

week we announced Tom’s new role,<br />

the Essilor-Luxottica merger was also<br />

announced and we were like, ‘oh we’re<br />

ready for this, that’s great’.”<br />

Eyepro had already replaced Essilor<br />

with CR Surfacing as its preferred lens<br />

supplier earlier this year, after Essilor<br />

decided to focus more on its Platinum<br />

Partners’ programme last year. Now,<br />

with Frowde at the helm, in a more<br />

dedicated role, Eyepro has added<br />

practice marketing company Optom Edge (see story p7), equipment<br />

supplier Device Technologies and Australian sunglass licensor and<br />

distributor Sunshades Eyewear to its list of preferred suppliers.<br />

Other partners include Misty Optic, CMI Optical, Eyes Right Optical,<br />

Healy, Coopervision plain label, Optica and Shamir OHS for safety<br />

lenses. Clark was also instrumental in ensuring all Eyepro members<br />

were recognised by Work and Income New Zealand (WINZ) when<br />

it rationalised its subsidy arrangements in the eye health sector a<br />

couple of years ago.<br />

In a statement, CR Surfacing, an Australian family-owned company<br />

with offices in Melbourne and Christchurch, said it was excited<br />

to be partnering Eyepro. “Our choice will always be independent<br />

as it supports and promotes New Zealand jobs with every dollar<br />

reinvested back into our local economies to provide a stronger future<br />

Chris Clark and Tom Frowde from Eyepro in Sydney for ODMA17<br />

for next generations.”<br />

Device Technologies’ Campbell<br />

Gordon, talking to NZ Optics at ODMA<br />

(see stories p10-16) said he’s also<br />

excited about the new partnership<br />

agreement as it gives Eyepro members<br />

some “great” deals and preferred<br />

pricing.<br />

Though the group negotiates<br />

“significant” pricing deals with<br />

preferred partners for members, no<br />

member is under any obligation to buy<br />

through Eyepro’s network, says Clark.<br />

“It’s a great opportunity to provide<br />

independents with alternatives so they<br />

can really compete with, say, $8 million<br />

advertising budgets!”<br />

Frowde says he’s trekked the length<br />

of New Zealand in his new role,<br />

visiting members to discuss the new<br />

partner arrangements and gain crucial<br />

feedback. “We aim to develop trusted<br />

working relationships and sustain<br />

our independents by improving their<br />

bottomline, while providing pricing<br />

security.”<br />

Optom Edge is a classic example of<br />

this, he adds, it’s optometry-specific<br />

and can provide independents with the<br />

marketing edge they need to stand out in their local communities.<br />

Clark is so impressed, he not only arranged for Optom Edge to build<br />

Eyepro’s new website, but says he’s also planning to talk to the<br />

company’s principal, former Essilor and Zeiss marketing manager,<br />

Robert Springer, about what more Curtis Vision should be doing in<br />

the online space.<br />

Eyepro’s also planning a series of education evenings for members<br />

run by preferred partners, like Device Technologies and Optom Edge,<br />

and considering a conference for members to share ideas. And there’s<br />

more supplier partnerships on the horizon. “We’ve never had so<br />

many friends in the wholesale industry,” laughs Frowde.<br />

In other news, Visique’s contract also ended with Essilor this month<br />

and was not renewed. Visique’s CEO Neil Human said he was unable<br />

to comment on supply arrangements. ▀<br />


University of Manchester spin-off company, MuMac is raising funds<br />

to commercialise its RapiDA test for early-stage age-related macular<br />

degeneration (AMD). According to MuMac, the “small, userfriendly”,<br />

patented RapiDA device can detect AMD often before any<br />

obvious biological changes in just five to 10 minutes.<br />


An artificial iris, manufactured<br />

from a light-controlled<br />

polymer material, can react<br />

to incoming light in the same<br />

ways as the human eye, say<br />

researchers from the Tampere<br />

University of Technology (TUT)<br />

in Finland. The false iris is made<br />

from a light-sensitive, liquid crystal elastomer developed using<br />

a photoalignment technology, also used in some mobile phone<br />

displays. The next step is to make the iris function in an aqueous<br />

environment, said lead researcher, Associate Professor Arri Priimägi.<br />


Rodenstock is the first lens manufacturer worldwide to offer TÜVcertified<br />

driving lenses, after the German product certification<br />

service company conducted a comprehensive user test on<br />

Rodenstock’s Impression Road 2 progressive lenses. The lenses were<br />

tested on a number of safe-driving criteria, including adaptation<br />

period, field of vision, glare, contrast and colour perception.<br />

RANZCO <strong>2017</strong> REGISTRATION OPEN<br />

Registration has opened for RANZCO’s 49th Annual Scientific<br />

Congress in Perth, from 28 October to 1 November <strong>2017</strong>. Early bird<br />

registration closes 6 September.<br />


2degrees’ Blind Foundation customers can now download<br />

magazines and books from the Foundation’s digital library using the<br />

audio BookLink app without paying for data.<br />


Vision 2020 Australia and CERA are planning a follow-up survey to<br />

their 2016 National Eye Health Survey to track progress in reducing<br />

the burden of blindness and vision impairment in Australia. Data<br />

collection will take place from September 2018 to April 2019 with<br />

the results published in the second half of 2019.<br />

New eye bank<br />

course<br />

The world’s first professional qualification<br />

course for eye bankers, the custodians of<br />

human tissue for eye transplant surgery,<br />

kicks off at Melbourne University in September.<br />

Associate Professor Graeme Pollock from the<br />

Centre for Eye Research Australia (CERA) and<br />

the Lions Eye Donation Service, is leading the<br />

academic and teaching team. Over the past<br />

20 years, the practice of eye donation and eye A/Prof Graeme Pollock<br />

banking has emerged as a profession in its<br />

own right, he says. “We hope to develop the future leaders of eye banking;<br />

professionals providing a clinical service to the ophthalmic community.”<br />

Louise Moffatt, who manages the New Zealand National Eye Bank,<br />

says she’s excited on behalf of the sector that this qualification is finally<br />

a reality due to the “incredible efforts” and vision of A/Profs Pollock and<br />

Heather Machin, project officer of the Lions Eye Donation Service. “The Eye<br />

Banking graduate certificate course offered at Melbourne University is a<br />

breakthrough for professional development for staff working in the sector.”<br />

Although Eye Banks provide internal training and education programmes,<br />

having access to an internationally-recognised university qualification will<br />

help eye banking be considered more as a profession rather than simply<br />

a set of technical processes, says Moffatt. The NZ National Eye Bank will<br />

sponsor one staff member each year to undertake the course.<br />

A/Prof Pollock says the course is ideal for those new to eye banking and<br />

those working in relevant sectors wishing to improve their knowledge and<br />

skills. “Graduates will transition beyond the fundamentals of eye banking<br />

and emerge as knowledgeable professionals and eye tissue custodians.<br />

They will develop skills that can be applied to all stages of eye tissue<br />

management including donor selection and recovery, recipient donor<br />

management, tissue examination and legal and regulatory requirements.”<br />

The online course has been developed by CERA and the Melbourne<br />

University together with the Eye Bank Association of Australia and New<br />

Zealand (EBAANZ) and Donatelife Australia.<br />

For more, visit: www.ebaanz.org ▀<br />

Bohème<br />

arrives in NZ<br />

Dynamic Eyewear has introduced Wayne Cooper’s new<br />

women’s eyewear range, Bohème, to New Zealand<br />

after it was launched at ODMA17, the first-time Wayne<br />

Cooper’s women’s frames have been available here.<br />

Director Paul Beswick says he’s excited to finally be<br />

introducing a range of the British-born, but well-known<br />

Australian-based designer’s women’s frames into New Zealand<br />

as the men’s ranges have been very popular. It just makes<br />

sense, he says, and people have been asking about when they<br />

can see a women’s range for some time, especially as Wayne<br />

Cooper is well-known for his women’s clothing designs.<br />

The collection will be sold alongside Dynamic’s Wayne<br />

Cooper’s men’s range, which the company has been<br />

distributing for seven years, since it begun.<br />

A mixture of metal and acetates, the Bohème range is<br />

bold and colourful, and looks expensive, but is surprisingly<br />

affordable, which is a key selling point in New Zealand, says<br />

Beswick. “It should<br />

appeal to women in New<br />

Zealand because he’s<br />

a well-known designer<br />

in the big department<br />

stores, like Smith &<br />

Caughey’s (in Auckland).”<br />

It also complements the<br />

company’s other ranges,<br />

such as Nicola Finetti (see<br />

p14), says Beswick, both<br />

of which are designed<br />

in tandem with Tiger<br />

Vision’s Tony Ghosen.<br />

“So we’ve got a lot to be<br />

excited about for this<br />

range.” ▀<br />

Dynamic Eyewear’s Paul Beswick with<br />

Australian designer Tony Ghosen<br />


California-based pharma-tech company, Verseon presented positive<br />

pre-clinical data on its eye-drop and oral delivery plasma kallikrein<br />

inhibitors for the treatment of diabetic macular oedema at the<br />

<strong>2017</strong> Bio International conference. Verseon’s drug candidates target<br />

the direct cause of downstream inflammation potentially lowering<br />

leakage into the retina, said the company.<br />


Coopervision has introduced MyDay toric daily disposable contact<br />

lenses for patients with astigmatism. The new lens offers a more<br />

comfortable and “healthier lens-wearing experience, UV inhibition,<br />

excellent lens stability and visual acuity,” said the company.<br />

www.nzoptics.co.nz | PO Box 106954, Auckland 1143 | New Zealand<br />

For general enquiries or classifieds please email info@nzoptics.co.nz<br />

For editorial, please contact Lesley Springall at lesley@nzoptics.co.nz or +64 27 445 3543<br />

For all advertising/marketing enquiries, please contact Susanne Bradley at susanne@nzoptics.co.nz or +64 27 545 4357 in the first instance, or Lesley Springall at lesley@nzoptics.co.nz<br />

To submit artwork, or to query a graphic, please email susanne@nzoptics.co.nz<br />

NZ Optics magazine is the industry publication for New Zealand’s ophthalmic community. It is published monthly, 11 times a year, by New Zealand Optics 2015 Ltd. Copyright is held by<br />

NZ Optics 2015 Ltd. As well as the magazine and the website, NZ Optics publishes the annual New Zealand Optical Information Guide (OIG), a comprehensive listing guide that profiles the<br />

products and services of the industry. NZ Optics is an independent publication and has no affiliation with any organisations. The views expressed in this publication are not necessarily<br />

those of NZ Optics 2015 Ltd or the editorial team.<br />

4 NEW ZEALAND OPTICS <strong>Aug</strong>ust <strong>2017</strong>

<strong>Aug</strong>ust <strong>2017</strong> NEW ZEALAND OPTICS<br />


Having a say in MD<br />

Passionate ophthalmologist and nurse specialist supporters<br />

of Macular Degeneration New Zealand (MDNZ) met in July to<br />

contribute to the government’s long-overdue action to better<br />

tackle macular degeneration care in New Zealand.<br />

Following the Royal Australian and New Zealand College of<br />

Opthalmologists’ (RANZCO’s) campaign to highlight the plight of<br />

many of the country’s MD patients, who were going blind while<br />

waiting for treatment, the government commissioned a Tier 3<br />

(model-of-care) report in age-related macular degeneration (AMD)<br />

from consulting firm Ernst & Young (EY) at the beginning of this year.<br />

MDNZ and many of its members have also worked tirelessly to<br />

get the government to act, commissioning its own report, “The<br />

socioeconomic cost of macular degeneration in New Zealand,” from<br />

Deloitte’s last year after becoming frustrated at the government’s<br />

lack of action and total absence of any funding to tackle the largest<br />

cause of visual impairment in Kiwis over 50 years old.<br />

Hence the interest in July’s MDNZ meeting, which was convened to<br />

allow the eye health community to get on board and provide crucial<br />

feedback to EY before it gives its report to government. The meeting<br />

was held at the Novotel in Ellerslie on the 1 July. There were 60<br />

leading retinal specialists from across the country, plus a number of<br />

ophthalmic nurses and other eye health practitioners. All participated<br />

in an afternoon of engaging discussions and presentations, which<br />

provided the catalyst for enthusiastic debate during the breaks.<br />

Engaging government<br />

The afternoon opened with a dynamic introduction from Phillippa<br />

Pitcher, MDNZ general manager, who outlined the fantastic work that<br />

MDNZ has been doing. Pitcher was followed by MDNZ marketing<br />

advisor James Rangihika who discussed ways of engaging with<br />

government. MDNZ’s key focus<br />

has been on increasing awareness<br />

of the condition within New<br />

Zealand: 1.5 million people are<br />

at risk of developing MD in New<br />

Zealand and this is forecast<br />

to increase to 1.8m in 2026.<br />

Awareness and education are key<br />

to reducing MD, hence MDNZ’s key<br />

message “early detection saves<br />

sight”. Deloitte’s report found<br />

the socioeconomic cost of MD in<br />

New Zealand to be a staggering<br />

$391m, though a $2.8m spend on<br />

awareness, based on comparable<br />

data in Australia and overseas,<br />

could save the government more<br />

than $70m a year.<br />

Increasing awareness<br />

In 2016, according to a poll, awareness of MD was at 59%. MDNZ’s<br />

aim is to increase this to more than 88% using a large-scale<br />

awareness campaign, including television advertising, emulating<br />

Australia’s success with such action. MDNZ currently creates<br />

awareness through an informative website, regular Facebook<br />

updates, its Viewpoint newsletter and regular educational roadshows<br />

around the country, encouraging people to contact MDNZ through its<br />

0800 ‘save sight’ help line, by email or through its website.<br />

New model-of-care<br />

At the meeting, EY’s Dr Gary Jackson took the audience through a<br />

Advanced Vision Care<br />

with AstaNZ - New Zealand Astaxanthin<br />



Supreme Health’s Advanced Vision Care formulation<br />

combines the power of AstaNZ (New Zealand natural<br />

Astaxanthin) with Lutein, Zeaxanthin and Saffron to create<br />

a comprehensive and powerful carotenoid complex<br />

to boost all aspects of eye health and protect the eye,<br />

whatever age you are.<br />

Astaxanthin is the only antioxidant, not naturally present<br />

in the eye, that can penetrate the retinal-blood barrier<br />

and protect every cell of the eye from oxidative stress.<br />

For more information about the product please visit our<br />

website – www.supremehealth.co.nz or contact us via<br />

email – sales@supremehealth.co.nz<br />

MDNZ supporters and attendees at the recent AMD Tier 3 Report discussion meeting<br />

draft version of its<br />

model-of-care for<br />

MD in New Zealand<br />

report. Key focus<br />

areas included<br />

prevention and<br />

early detection,<br />

intravitreal anti-<br />

VEGF treatments<br />

and low vision<br />

rehabilitation.<br />

A visionary and<br />

enthusiastic Dr<br />

Dianne Sharp, chair MDNZ’s James Rangihika and chair Dr Diane Sharpe<br />

of MDNZ, urged<br />

ophthalmology<br />

colleagues to offer<br />

their feedback before<br />

the report is put<br />

before government.<br />

“This is our chance<br />

to have our say –<br />

let’s make it count!”.<br />

Ophthalmologists<br />

were invited to<br />

discuss the accuracy<br />

of the picture of<br />

Drs Rachel Barnes, Narme Deva and Kanapath Sivasuthan<br />

the current state<br />

of care and the<br />

proposed new<br />

model-of-care to<br />

develop and provide<br />

useful feedback<br />

to EY prior to<br />

submitting its advice<br />

to the Ministry of<br />

Health. The key<br />

objective was: timely<br />

diagnosis, close to<br />

home and the best Sarah Piluden, Robyn Cochrane and Michele Cummins<br />

use of professional<br />

skills, technology and infrastructure in the health system. Dr Jackson<br />

also discussed early detection of MD and speed of treatment, with<br />

the aim to reduce time from diagnosis to the patient’s first anti-<br />

VEGF injection to one week or less to decrease the total number of<br />

injections used per patient. (See story p20).<br />

Ophthalmologists gave feedback and there was lively discussion<br />

about anti-VEGF treatment options and availability, the potential of<br />

using other eye health professionals to administer injections and the<br />

administration challenges within the public health system. Everyone<br />

agreed the sessions provided many interesting talking points and<br />

useful feedback for EY.<br />

Clinical examples<br />

Led by Dr David Squirrel, the final session of the afternoon opened<br />

the floor to those ophthalmologists present to discuss challenging<br />

clinical cases and their own rationales and considerations for the<br />

application of anti-VEGF treatments.<br />

MDNZ professional friends<br />

Pitcher thanked those ophthalmologists who have joined the MDNZ<br />

Professional Friend member support programme and encouraged<br />

others to join. If optometrists or ophthalmologists are interested in<br />

becoming a Professional Friend of MDNZ, please visit: www.mdnz.<br />

org.nz. ▀<br />

All new in dry eye<br />

New, Kiwi-designed non-contact corneal device<br />

launched plus the latest on all things dry eye in<br />

September’s NZ Optics<br />

K<br />

iwi ophthalmologist, Dr Simon Dean has designed and<br />

developed a novel, non-contact corneal aesthesiometer (NCCA)<br />

that is currently being trialled as part of an exciting new research<br />

study investigating cold pathways in corneal health and disease.<br />

This and many other ground-breaking studies and the latest<br />

thinking on dry eye disease from this part of the world will<br />

be covered in detail in our popular Dry Eye Special Feature in<br />

September’s NZ Optics.<br />

To advertise, please email: lesley@nzoptics.co.nz<br />

6 NEW ZEALAND OPTICS <strong>Aug</strong>ust <strong>2017</strong>

The end of Visionz?<br />

After more than 35 years, the biennial New Zealand<br />

optical industry-run conference Visionz is unlikely<br />

to happen in 2018 or for the foreseeable future<br />

after the Association of Dispensing Opticians of New<br />

Zealand (ADONZ) have opted to go it alone for their 2018<br />

conference.<br />

Up to and including the 2012 event, Visionz used to<br />

combine its biennial exhibition with the annual meetings<br />

and conferences of both ADONZ and the New Zealand<br />

Association of Optometrists (NZAO). NZAO opted to go<br />

it alone for both the 2014 and the 2016 events, despite<br />

“several months of discussions,” according to New Zealand<br />

Optical Wholesalers Association president, Gary Edgar. This<br />

left ADONZ as Visionz’ sole partner, leading to a significant<br />

drop in attendance, not helped by the NZAO conference<br />

being held on the same weekend as the Visionz/ADONZ<br />

conferences in 2016.<br />

ADONZ surveyed its members following the 2016 event<br />

and wrote to Edgar in June saying its executive committee<br />

had decided to hold its conference independently of the<br />

NZOWA trade fair in 2018, and would be holding it on<br />

27-29 October, 2018, to ensure it didn’t clash again with<br />

NZAO’s 2018 event on 13-15 October in Paihia.<br />

Donald Crichton, ADONZ vice-president, told NZ Optics<br />

the main purpose of the ADONZ conference is to provide<br />

CPD for its members and hold its AGM. Like NZAO, ADONZ<br />

is restricted to a tight timeframe for holding its AGM<br />

making it difficult to coordinate what it needs to provide for<br />

members with the wants and wishes of other organisations.<br />

It’s unlikely Visionz will happen again, as it once did, said<br />

Crichton. “In other markets the wholesalers have trade<br />

shows at neutral times of the year and anyone who wishes<br />

to attend is able. The issue with a trade show at the same<br />

time as a conference is the lack on contact the delegates<br />

have with the wholesalers due to their commitment to<br />

attend lectures, leaving precious little time to meet with<br />

frame, lens and equipment suppliers.”<br />

NZAO president Callum Milburn concurred with ADONZ,<br />

saying it is difficult to simultaneously meet the needs<br />

of NZAO, NZOWA and ADONZ. “(It’s) not that the NZAO<br />

does not wish to support the industry, suppliers or the<br />

companies which make up the NZOWA. Indeed, our<br />

members who have buying privileges for their practices<br />

give strong support to our local New Zealand suppliers. For<br />

many there exist relationships spanning decades and even<br />

generations! That said, there is a need for understanding<br />

that times change and… as health professionals our<br />

members, and by extension our association, must<br />

maintain a strong focus on professional matters including<br />

professional<br />

competence,<br />

maintaining evidencebased<br />

healthcare<br />

standards and keeping<br />

informed of new treatment<br />

modalities and emerging<br />

technologies in order to future-proof the<br />

profession and their individual careers.”<br />

The core business of the NZAO is to oversee the<br />

professional development of optometry in New Zealand<br />

and to explore every opportunity to ensure optometrists<br />

are permitted and encouraged to practice to the fullest<br />

extent of their scope, he said. “The NZAO also has a<br />

mandate to foster collegiality amongst membership, who<br />

nowadays practice in such a diversity of settings, be that<br />

commercial, hospital or educational.”<br />

Milburn said the NZAO would welcome the establishment<br />

of a comprehensive New Zealand trade fair and associated<br />

education forum at a date which didn’t conflict with the<br />

NZAO’s national conference and would be attractive for<br />

all optometrists and DOs to come together, with plenty of<br />

time to view and experience the products on offer.<br />

Edgar said he’s disappointed, but NZOWA understands<br />

the concerns of NZAO and ADONZ. Though 2018 won’t be<br />

happening at this stage, NZOWA will continue to explore<br />

other options for the future with its members and the NZAO<br />

and ADONZ, he said. “It’s just one of those things. It is a<br />

shame. The industry is changing and we have to accept that,<br />

but the door is open for discussion as it has been all along.”<br />

This year’s NZAO conference is taking place in Hamilton<br />

from13-15 October, while ADONZ conference is in<br />

Christchurch on the same weekend.<br />

NZOWA<br />

The New Zealand Optical Wholesalers Association<br />

(NZOWA) held its AGM on 16 June. The following officers<br />

were appointed:<br />

President: Gary Edgar<br />

Treasurer: Rae Long<br />

Committee members: Trish Orr, Glenn Bolton, Gary Edgar<br />

and Rae Long<br />

Safety Committee: Albie Hanson (safety standards) and<br />

Nigel Butler (fashion standards)<br />

The NZOWA has 31 members, as listed in the <strong>2017</strong> Optical<br />

Information Guide.<br />

Optom Edge in NZ<br />

After 18 months honing its<br />

abilities in Australia, practice<br />

marketing company Optom<br />

Edge is poised to introduce New<br />

Zealand optometry practices to its<br />

dedicated, optometry marketingfocused<br />

capabilities.<br />

The still relatively new company<br />

has just been named as a preferred<br />

partner of the Kiwi independent<br />

optometry group Eyepro (see<br />

story p4), which is planning some<br />

education evenings later this year<br />

to both promote Optom Edge and<br />

upskill its members’ social marketing<br />

abilities.<br />

Optom Edge was founded by<br />

Robert Springer, formerly a marketing<br />

manager for both Essilor and Zeiss,<br />

and now employs four people. It<br />

helps practices define themselves<br />

and market themselves better<br />

online through, among other<br />

things, building better patient recall<br />

templates and websites; helping with<br />

Facebook business page setups and<br />

management; establishing patient<br />

feedback mechanisms; connecting<br />

to online reviews; and advising on online<br />

advertising, via Google and Facebook, and<br />

custom-built marketing campaigns.<br />

Eyepro is already putting Optom Edge’s<br />

abilities to the test having engaged Springer<br />

to write its new website and help with its<br />

own online marketing abilities. Optom<br />

Edge works with most Australasian practice<br />

management software systems, allowing it<br />

to take data from the systems and send it<br />

to automatic marketing programmes. This<br />

data can be personalised and targeted quite<br />

easily by the practice’s dedicated marketing<br />

person, says Springer. “The idea is to make<br />

it easy for the practices. We’re not an<br />

outsource solution, we provide the tools<br />

and the training so the practices can do this<br />

themselves, or we can provide a managed<br />

service if that’s what they prefer.”<br />

Springer says he’s excited to finally be<br />

launching in New Zealand as Kiwis are<br />

Robert Springer launching Optom Edge in NZ<br />

known to be early technology adopters<br />

and aren’t afraid of trying new things. The<br />

problem, however, is many still see digital<br />

marketing as simply putting a regular post<br />

up on Facebook. “They are putting content<br />

out there, but they are not connecting it to<br />

an actual purpose. There’s no real measure<br />

or expectation of that patient or even who<br />

that patient is. But these platforms can<br />

help you be really efficient in reaching your<br />

audience.”<br />

Optom Edge can also help with a practice’s<br />

day-to-day business, by staggering recalls,<br />

for example, to smooth out bookings. “We<br />

just need the lists and then we can help<br />

evaluate what the practice has and help<br />

them get where they want to get to.” ▀<br />

For more on the importance of online<br />

referrals, see “Facing the Feedback” in NZ<br />

Optics’ May <strong>2017</strong> issue, featuring more<br />

online advice from Springer.<br />

Passionate<br />

about vision<br />

For the specialist treatment of all eye conditions<br />

our rooms provide generous consulting and<br />

treatment space, state of the art technology,<br />

an innovative layout to increase comfort and<br />

plenty of free and easily available parking.<br />

Most importantly, it also provides the home for a proudly local<br />

team. As the number one South Island provider of specialist<br />

ophthalmic care our surgeons are fellowship and New Zealand<br />

trained sub-specialists. They are experts in their respective fields.<br />

They are excited to be part of our new city, to be the care behind<br />

the change, the insight behind the vision.<br />

Dr James Borthwick<br />


Disease and surgery of the retina and macula, cataract<br />

Dr Sean Every<br />

MB ChB, MMedSci (Distinction), FRANZCO<br />

Disease and surgery of the retina and macula, cataract<br />

Dr Jo-Anne Pon<br />


Oculoplastics, cataract, neuro-ophthalmology,<br />

strabismus, general ophthalmology<br />

Dr John Rawstron<br />

MB ChB, MPH, GDipM (Refract Surg), FRANZCO<br />

Cataract, LASIK, corneal transplant<br />

Dr Rebecca Stack<br />

MB ChB (Distinction), MMedSci, FRANZCO<br />

Cataract, oculoplastic and reconstructive surgeon<br />

Dr Allan Simpson<br />


Cataract, glaucoma<br />

Dr Robert Weatherhead<br />


Oculoplastic and reconstructive surgeon<br />

Dr Logan Robinson<br />

MB Chb, PG Dip Ophth BS (Distinction), FRANZCO<br />

Vitreoretinal surgery, diseases of the retina<br />

and macula, refractive cataract surgery<br />

Centrally located, find us at 128 Kilmore Street, Christchurch ı P: 03 355 6397 ı W: www.southerneye.co.nz<br />

<strong>Aug</strong>ust <strong>2017</strong><br />



Don’t stop till you get enough<br />

The conventional idea of retirement is to stop work at age 65 and put your feet up at home.<br />

But for many eyecare professionals, it seems that’s an outdated concept. By Cait Sykes.<br />

At the end of the week he chats to NZ Optics<br />

for this story, Paul Rose CNZM, is heading off<br />

to the Middle East and Europe. But the trip<br />

is for business, not pleasure; he’s embarking on a<br />

five-week lecture tour.<br />

It’s not an uncommon occurrence for the inventor<br />

of the Rose K lens, whose schedule has typically<br />

seen him lecturing offshore for three months a<br />

year. Rose describes his working life today as about<br />

“80% full-time”, with his contract consulting work<br />

for Japanese company Menicon (which bought the<br />

company he co-founded, Rose K International, in<br />

2008) consuming most of that. However, he’s also<br />

still developing new products and is a 50% owner<br />

of Hamilton-based practice, Total Vision.<br />

Despite ‘retiring’ from practising optometry,<br />

nine-to-five, around eight years ago, Rose says<br />

there are<br />

many factors<br />

that have<br />

allowed him<br />

to maintain<br />

a dynamic<br />

working life<br />

despite being<br />

a handful<br />

of years<br />

beyond the<br />

conventional<br />

age of<br />

retirement.<br />

Opportunity<br />

Paul Rose, “today’s 70 is the new 60”<br />

is one, through<br />

the likes of his work with Menicon. Technology,<br />

which increasingly facilitates more mobile and<br />

flexible working arrangements, is another. Good<br />

mental and physical health also play their role.<br />

An active retirement: the new norm?<br />

But Rose asserts he’s not an anomaly when it<br />

comes to eschewing the conventional idea of<br />

retirement – that you stop work and put your feet<br />

up at age 65.<br />

“I think today’s 70 is the new 60,” says Rose.<br />

“Today you don’t consider yourself ‘old’ at 70 if you<br />

still have your physical and mental wellbeing, so<br />

you tend not to consider retirement. We have this<br />

huge number of older people coming through who<br />

can still contribute a lot to the workforce and, yes,<br />

there may be financial reasons for that, but it’s also<br />

a reflection of people’s health and their attitudes<br />

to old age.”<br />

Statistics back up Rose’s observations. In 2016<br />

around 24% of New Zealanders aged 65 and over<br />

were working either full or part-time. And for<br />

those aged between 65 and 69 years, that figure<br />

rose to 43%.<br />

David Boyle, general manager of education at<br />

the Commission for Financial Capability, says that<br />

latter figure is high relative to other countries and<br />

is perhaps influenced by the fact New Zealanders<br />

aged 65-plus can access NZ Super whether they’re<br />

working or not.<br />

But ultimately, as Rose intimates, greater<br />

longevity is driving the changes we’re seeing<br />

around the ageing population’s increasing<br />

participation in the workforce.<br />

“Personally I’m not a fan of the word ‘retirement’,”<br />

says Boyle. “When you look that up in the dictionary<br />

it basically says that’s when you stop; when you<br />

stop work, when you stop earning an income.<br />

And as those statistics show, New Zealanders<br />

increasingly aren’t doing that for a whole lot of<br />

reasons – and not just because they have to.”<br />

Boyle points to the findings of a survey<br />

carried out by the Commission that canvassed<br />

around 3,500 people aged over 65 about their<br />

participation in the workforce, including what<br />

motivated them to work.<br />

About 54% said they had to keep working<br />

for financial reasons, but the remaining 46%<br />

cited other reasons, such as gaining a sense of<br />

purpose, contributing to the community, being<br />

socially connected and passing on knowledge and<br />

expertise to the next working generation.<br />

The survey also found, however, that older New<br />

Zealanders had some fears they wouldn’t be<br />

able to enjoy their later years if they had to keep<br />

working to the extent they had been.<br />

“Something more and more New Zealanders are<br />

thinking about is how to have flexibility so they<br />

can enjoy their later years but also still contribute<br />

and make a little bit of money along the way. It can<br />

be a difficult transition, which is why it’s so crucial<br />

for people to start jotting down a plan about<br />

what’s important to them, both career-wise and<br />

personally.”<br />

For many, striking that balance comes by taking<br />

an incremental approach to the transition into<br />

retirement.<br />

Avoiding retirement “death”<br />

Retired optometrist Hywel Bowen learnt some<br />

early lessons on how not to approach retirement<br />

when he began practising in Thames, the town<br />

he’s called home for 39 years.<br />

“When I first came here I noticed that a lot of<br />

“Personally I’m not a fan of the word ‘retirement’. When you look<br />

that up in the dictionary it basically says that’s when you stop;<br />

when you stop work, when you stop earning an income.”<br />

retired farmers would move into town and go<br />

from working 80 hours a week to nothing. Then six<br />

months later they’d be dead. That really struck me<br />

and I’ve always been aware of that danger.”<br />

Bowen was 52 when he sold his busy practice,<br />

which typically saw him working 55-hour-plus<br />

weeks. He then worked as a locum for three years<br />

in different locations around the country, and a<br />

further three in Thames. Originally full-time, he<br />

dropped down to four days a week, then to three<br />

once working back in Thames, before retiring<br />

around 18 months ago.<br />

“Mentally, working for someone else is not so<br />

exhausting. And working part-time gives you time<br />

to develop other interests and a broader social<br />

base in the community you live in.”<br />

Bowen describes a life that’s always been active:<br />

he spent six years on the New Zealand Association<br />

of Optometrists (NZAO) Council, five years on the<br />

Optometrists and Dispensing Opticians Board<br />

(ODOB), lectured intermittently at university, and<br />

has done 19 trips with Volunteer Ophthalmic<br />

Services Overseas (VOSO) – his first in 1984.<br />

He’s also a former VOSO chair and secretary, and<br />

remains a trustee. In his local community, he’s<br />

been involved with schools and Scouts, and he’s<br />

been a Rotary member for the past 14 years and is<br />

currently secretary of his club.<br />

So even in his retirement proper, there seems<br />

little inclination to put his feet up.<br />

“In terms of interests, family is the main thing:<br />

I’ve got three<br />

kids and four<br />

grandkids<br />

now. I keep fit<br />

with tramping<br />

and cycling.<br />

Last year<br />

I did ‘Tour<br />

Aotearoa’,<br />

where you<br />

bikepack<br />

from Cape<br />

Reinga to<br />

Bluff, and I’m<br />

doing it again David Boyle, “retirement” is the wrong word<br />

next year.<br />

It’s 3,200km, and over that distance I climbed the<br />

equivalent of Mt Everest 3.3 times – there are a lot<br />

of hills in New Zealand.”<br />

Mike Firmston first ‘semi-retired’ more than<br />

20 years ago, when he and his brother-in-law<br />

and business partner Bryan Matthews sold their<br />

Optique Eyewear chain to OPSM in 1995. In the<br />

ensuing five years, however, Firmston ended up<br />

working in the corporate world for OPSM, gaining<br />

experience and insights he likens to doing an MBA.<br />

So when Matthews came knocking with an idea<br />

for a new business, Specs Direct, he jumped at the<br />

chance to put that business experience to work in<br />

another venture, and any further retirement plans<br />

went on hold.<br />

It was just over a year ago, at age 70, that<br />

Firmston really retired, when he and Matthews<br />

sold their business to a senior optometrist who’d<br />

been working in their firm for about 20 years.<br />

Firmston too has had a busy professional life,<br />

including nine years on the board of ODOB and as<br />

a director of training organisation Opti-Blocks – a<br />

role he still holds. He also continues to be involved<br />

in optical wholesale company Tranz Optics, which<br />

he co-owns with Matthews.<br />

“When I was young and the children were<br />

growing up it was my wife that carried the burden<br />

of bringing up the family. I’d arrive home in the<br />

evening and just be able to get them in the bath<br />

and read a story then you’re off fairly early in the<br />

morning again. All those years I felt like I wanted<br />

to invest more in family time,” explains Firmston.<br />

“But I thought the looming challenge for me with<br />

retirement would be the balancing act, because I<br />

knew I wouldn’t just be able to put my feet up.”<br />

8 NEW ZEALAND OPTICS <strong>Aug</strong>ust <strong>2017</strong>

Finding time for smaller joys<br />

Firmston admits he’s thoroughly enjoying<br />

retirement: spending time and helping out with<br />

their five children and nine grandchildren, and<br />

doing a bit of domestic and international travel. He<br />

also does some volunteer work and has a long list<br />

of other groups he’d like to contribute to.<br />

“There are all those things you’ve been<br />

associated with in a small way in your life, and I<br />

had this list of things I’d maybe like to do when I<br />

retired. But I thought to myself, the challenge is<br />

going to be having the time to be able to do all<br />

those things and still have the flexibility I want.”<br />

Like Firmston, Rob Allan has had the transition<br />

towards retirement smoothed thanks to a business<br />

succession opportunity. In Allan’s case his son and<br />

daughter-in-law are now the owners of what was<br />

his Whangarei-based optometry practice, Lowes<br />

& Partners. But despite Allan receiving his official<br />

retirement send-off alongside last year’s annual<br />

Christmas party, he’s still working in the business.<br />

It’s a symptom of the perennial problem faced by<br />

many healthcare practice owners in provincial New<br />

Zealand – finding staff, he says.<br />

“It was my intention to gradually reduce my<br />

hours, but really what dictates how much work I<br />

do is the staffing levels at any given time. At one<br />

point I was doing 60 hours a week. That’s not<br />

necessarily what I would wish or what the current<br />

owners would wish, but it’s what the business<br />

dictates.”<br />

As with Bowen and Firmston, Allan is well<br />

accustomed to a busy professional life. During<br />

his first 20 years in practice in Scotland, he<br />

represented his fellow optometrists at local<br />

association level, then at the Scotland-wide<br />

level and nationally, as part of the Association of<br />

Optometrists’ Council. In New Zealand, where he’s<br />

practised for 30 years, he’s been a member of the<br />

NZAO Council.<br />

Allan is currently working part-time until a<br />

replacement can be found for a staff member who<br />

left mid-year. Once that happens, however, he still<br />

anticipates continuing his work in the business<br />

mentoring staff on specialist contact lens work,<br />

although, he adds with a smile, “I have been<br />

playing a lot more golf”.<br />

Plan for the unexpected<br />

Stu Allan (no relation) is founder of practice support<br />

consultancy OpticsNZ and says some of the best<br />

examples he’s seen of successful transitions into<br />

retirement are when the practitioner continues to<br />

work in the business once they’ve sold it, either as<br />

an employee or consultant.<br />

“A gradual departure from the business<br />

establishes a win-win outcome,” says Allan. “The<br />

new owner is able to leverage the goodwill and have<br />

a mentor to call upon; the retiree is able to slowly<br />

exit the profession with respect and dignity.”<br />

However Allan says there are a range of factors<br />

that may make it more challenging for practice<br />

owners to sell their operations today than in<br />

the past. In particular, greater competition in<br />

optometry makes it harder to realise financial<br />

returns, while advances in technology bring<br />

increased demands for capital investment, he says.<br />

“There are some practice owners that are on<br />

the front foot and really well planned. They have<br />

all the financial information to take a practice to<br />

market, and the really switched-on ones realise<br />

they do want to step away from the emotional<br />

commitment and sell something they’ve built up,<br />

in some cases over 30 to 40 years.”<br />

However, those who haven’t planned well can<br />

find themselves in a tight spot, for example if<br />

they have to sell fast due to poor health, he says,<br />

while another challenge of transitioning out of<br />

working life, is the potential emotional and social<br />

disconnection that can occur.<br />

Allan’s not alone in his observation. Given<br />

eyecare professionals work so closely with people<br />

and make tangible differences to their lives,<br />

many spoken to for this story talked about the<br />

importance of maintaining that sense of social<br />

connection and contribution to the community<br />

during the transition into retirement and beyond.<br />

Retiring when you’re ready<br />

Esteemed ophthalmologist Associate Professor<br />

Bruce Hadden CNZM retired from surgery at age<br />

Rob Allan (centre) celebrating his not-retiring-yet party with family and colleagues<br />

67 and worked a further four years as a consultant.<br />

Then, at the urging of University of Auckland<br />

ophthalmology chair, Professor Charles McGhee,<br />

A/Prof Hadden went on to write a book on the<br />

history of ophthalmology in New Zealand and<br />

complete a Doctorate in Medicine, alongside<br />

teaching optometry and medical students (the<br />

latter he still does as needed).<br />

But A/Prof Hadden is about to depart for Europe<br />

when he chats to NZ Optics, with plans to spend<br />

a week walking in Ireland, then on to London<br />

and Switzerland to spend time with family. A/<br />

Prof Hadden characterises himself as almost fully<br />

retired now, and says although he’s happy at this<br />

stage in his life he’s not as fulfilled as he was in the<br />

prime of his career.<br />

“There’s no question that you miss the feeling<br />

of fulfilment that one gets from contributing to<br />

people, contributing to society, contributing to<br />

ophthalmology and its organisation, contributing<br />

to the College (RANZCO) and ensuring the next<br />

generation is adequately educated for their<br />

responsibilities. I would advise people to think long<br />

and hard about that and not to retire before they<br />

need to because once you’ve done it you can’t turn<br />

the clock back.”<br />

Despite “not being able to hit a golf ball to save<br />

myself”, Hadden has jogged all his life and these<br />

days also catches up for coffee with a group of<br />

like-minded locals four days a week, who regularly<br />

gather for cycling expeditions as well.<br />

“What becomes more and more important as<br />

you have less and less to do is to maintain your<br />

friendships with many people and keep active. If<br />

you don’t use it, you lose it – and that applies to<br />

your brain and your body.” ▀<br />

FOR SOME,<br />


A dragonfly’s sight is<br />

unrivalled in the insect<br />

world. With the largest<br />

compound eyes containing<br />

around 30,000 individual<br />

facets and up to 5 visual<br />

opsins, it can perceive the<br />

full colour spectrum as well<br />

as UV light and importantly,<br />

light polarization. Its<br />

highly-evolved optic system<br />

helps the dragonfly in<br />

navigation and reducing<br />

the sun’s glare on water.<br />



Like the dragonfly, NuPolar is the true<br />

ruler of its domain. It consistently outperforms<br />

other polarized prescription<br />

lenses and will give your patients the<br />

ultimate visual experience. NuPolar sets<br />

a benchmark for stringent performance<br />

characteristics of optics, polarized film<br />

technology, colour consistency, material<br />

sciences and more. It is the accepted<br />

global standard for polarized lenses.<br />



GREY/<br />

GREY<br />

BROWN/<br />

GREY<br />

BROWN/<br />

BROWN<br />


The leading light in polarization<br />

youngeroptics.com.au<br />

NuPolar and Trilogy are trademarks of Younger Mfg. Co. Trivex is a registered trademark of PPG Industries Ohio, Inc. www.youngeroptics.com ©<strong>2017</strong> Younger Mfg. Co.<br />

YNG0013<br />

<strong>Aug</strong>ust <strong>2017</strong><br />




From the chair<br />


The ODMA board’s main objective for<br />

ODMA17 was to deliver a current, well-run<br />

and immaculately presented centerpiece<br />

for our Industry that would deliver returns<br />

for our exhibitors. The board worked equally<br />

as hard to ensure there was a fresh feeling of<br />

excitement and optimism that visitors and<br />

exhibitors could embrace. I believe, on the whole,<br />

ODMA17 fulfilled that objective even going<br />

beyond expectation in many areas. This was a<br />

very important outcome for the board and the<br />

industry as, after a six-year absence from Sydney,<br />

ODMA needed to be a success that showcased<br />

From the CEO<br />


One of the highlights of ODMA17 was the<br />

variety of educational options. The Vision<br />

Summit speakers were all world class<br />

leaders in their field including IPL dry eye technology<br />

inventor, Dr Rolando Toyos, from the US, who went<br />

on to demonstrate how IPL works on the show floor<br />

every day. Our Masterclasses were also a big hit and<br />

included future-proofing-the-industry topics by<br />

Elaine Grisdale, from ABDO in the UK, and Dr Leigh<br />

Plowman from Optomly, who showed ECPs how<br />

to maximise their use of Facebook. A number of<br />

important and current topics were also covered each<br />

day on the Knowledge Centre Stage, such as ‘How<br />

much is your practice really worth’ by Kathy Allen of<br />

Dewings Accountants and ‘Keeping one step in front<br />

of Amazon and other online ordering threats’ by Jeff<br />

McAnnally from Lunovus in the US.<br />

Design Junction showcased high-end<br />

international and Australian eyewear brands, with<br />

exhibitors presenting their design capabilities and<br />

the very latest in optical fashion and innovation,<br />

within the premier brands area of ODMA17. This<br />

was a great start for a new zone and included<br />

leading optical designers and distributors Jono<br />

the strength and unity of our industry association<br />

and set groundworks for future events. Many of<br />

the exhibitors I spoke with enjoyed better-thananticipated<br />

returns with business written on the<br />

stand and plenty of post-ODMA appointments<br />

and leads to follow up.<br />

I would like to congratulate ODMA CEO Finola<br />

Carey and the IEC Group who did a magnificent<br />

job with the organisation of ODMA17, going<br />

way beyond what we have experienced for<br />

many ODMAs. Finally, I would like to thank the<br />

many visitors to ODMA17 who played such an<br />

important part of making the fair successful.<br />

Onwards to O-Show in 2018 and ODMA19.<br />

Hennessy Group, Healy Optical, VSP Australia,<br />

Mondottica, Pelure, Nine Eyewear, Face Optics,<br />

Seen2see and Frost Eyewear Distribution.<br />

ODMA is continuously reshaping its offering<br />

to the industry, but the core of what we do has<br />

not changed substantially because that is what<br />

the industry wants. After every event we survey<br />

members, exhibitors and visitors and tailor each<br />

new event to their specific feedback. ODMA also<br />

ploughs all the proceeds from its events back<br />

into projects that support the Australian Optical<br />

Industry.<br />

We look forward to welcoming you to our next<br />

event next year.<br />

ODMA CEO Finola Carey with Rachel Brockless, Janelle Coates,<br />

Kristine Hammond and Donald Crichton at ODMA17<br />

Strong exhibitor support<br />

for ODMA17<br />


Though numbers were down on previous fairs,<br />

the Optical Distributors & Manufacturers<br />

Association of Australia (ODMA) <strong>2017</strong> trade<br />

fair was abuzz with activity, especially on the<br />

Saturday, despite the fair being held in the middle<br />

of Australian school holidays.<br />

Nearly 3,300 visitors (not including exhibitors or<br />

media) attended the three-day fair, including more<br />

than 30 New Zealanders, many brought by Essilor.<br />

Only 150 delegates attended the Vision Summit,<br />

however, despite the high calibre of speakers, but 495<br />

went to the Masterclasses, leaving no spaces for late<br />

arrivals at some of the sessions.<br />

Though visitor numbers were low, which was<br />

expected given the launch of rival fair Silmo<br />

Sydney earlier in the year (at the same venue),<br />

there was strong support from the industry with<br />

110 exhibitors, including 21 equipment suppliers<br />

and 54 frames suppliers. Most categories were well<br />

represented, except contact lenses, with Alcon as<br />

the only commercial representative.<br />

Those exhibitors approached for comment by NZ<br />

Optics said the show had been successful as there<br />

were a number of active buyers among attendees<br />

and there was plenty of time to discuss more<br />

complicated devices with interested parties. The<br />

champagne flowed at many stands each evening,<br />

and the central bar was so popular on the Friday<br />

evening, it’s opening hours were extended by a<br />

very welcome extra hour.<br />

The following includes exhibitor highlights and<br />

news from the <strong>2017</strong> fair:<br />

VSP Australia: Etro<br />

Dominating the view when you entered ODMA,<br />

VSP Australia’s (formerly General Optical’s) large<br />

stand was adorned not only by a plethora of<br />

eye-catching frames, but also a couple of even<br />

more eye-catching, relatively scantily-clad people<br />

modelling examples of the company’s popular<br />

Calvin Klein Collection.<br />

Attempting to compete with this diversion, was<br />

new New Zealand representative Ryan Williams<br />

(see story p25) who was keen to introduce ODMA<br />

visitors to VSP’s new Italian brand Etro’s new<br />

paisley-inspired collection. Aimed at men and<br />

women over 30, Etro uses prints and colours that it<br />

describes as appealing to “the urban traveller who<br />

loves deconstructed elegance… and is passionate<br />

with colours and sophisticated details.” Describing<br />

it as “amazingly beautiful”, Williams says the new<br />

Etro range will be available in New Zealand from<br />

the end of July.<br />

Another focus for ODMA, and also a new luxury<br />

signing for Marchon (VSP’s eyewear company), was<br />

the French brand Longchamp. Under the design<br />

and creative direction of Sophie Delafontaine,<br />

Longchamp’s artistic director, a new line of<br />

women’s frames and sunglasses has just been<br />

released. French luxury House Longchamp was<br />

founded in Paris in 1948 by Jean Cassegrain, and is<br />

still owned and run by the Cassegrain family. The<br />

family describe the brand as epitomising French<br />

flair with “fresh and inspiring creativity” for those<br />

“who enjoy a touch of luxury every day”.<br />

Marchon’s other brands, distributed by VSP<br />


Update your<br />

customers’ eyes<br />

for better vision.<br />

ZEISS Lenses for Digital Life<br />

We live in a digital world where<br />

everybody is connected through<br />

modern communication tools. After a<br />

long day and many hours focusing on<br />

digital screens and being surrounded<br />

by artificial light, nearly everybody<br />

is familiar with challenges such as<br />

Digital Eye Strain.<br />

Offering the widest and most<br />

technologically advanced range of<br />

ZEISS Lenses for Digital Life - there is<br />

a digital vision solution for all of<br />

your customers.<br />



www.zeiss.com.au/vision<br />

10 NEW ZEALAND OPTICS <strong>Aug</strong>ust <strong>2017</strong>

INTRODUCING AIR OPTIX ® plus HYDRAGLYDE ® contact lenses<br />

THIS IS WHY your<br />

patients can have excellent<br />

deposit protection, now with<br />

longer-lasting moisture 1-3<br />



The excellent deposit resistance of AIR OPTIX ®<br />

brand contact lenses, now combined with<br />

the enhanced moisture benefits of<br />

HydraGlyde ® Moisture Matrix,<br />

designed to keep the lens surface<br />

moist throughout the day. 1,2,4<br />

Contact your Alcon ® Business<br />

Development Manager to learn more.<br />



Featuring proprietary AIR OPTIX ® brand<br />

lens technology, which has demonstrated<br />


DAY 1 TO DAY 30 5 *<br />



+8.00D TO -12.00D<br />

NEW<br />


References: 1. Nash W et al. A comparison of various silicone hydrogel lenses; lipid and protein deposition as a result of daily wear. Optom Vis Sci<br />

2010;87:E-abstract 105110. 2. Alcon data on file, 2015. 3. In vitro wetting analysis: out-of-pack and wetting substantivity. Alcon data on file, 2014.<br />

4. In vitro study over 16 hours to measure wetting substantivity; Alcon data on file, 2015. 5. Eiden SB et al. Prospective study of lotrafilcon B lenses<br />

comparing 2 versus 4 weeks of wear for objective and subjective measures of health, comfort, and vision. Eye & Contact Lens 2013;39(4):290–294.<br />

@ 2016 Novartis. Alcon Laboratories (Australia) Pty. Ltd. ABN 88 000 740 830. Australia Phone: 1800 224 153. New Zealand Phone: 0800 101 106<br />

11/16 ALC0575 nzoptics NP4:A21611553818.<br />

<strong>Aug</strong>ust <strong>2017</strong><br />




Optique Line’s Mersey Beat<br />

Optique Lines’ John Nicola and Sean Young with Hans Stepper (centre)<br />

Bruce Little, Centervue’s Fabian Cedrati, Craig Norman and Barbara Collis on the<br />

Optimed stand<br />

ILS’ John Clemence and Glenn Bolton<br />

Ralph Paterson and Tim Way MSO’s Rae Long and Gethin Sladen on the Eyes Right stand DFV’s Brad Grills (third) and team celebrating “the mullet” ODMA bustling on the Saturday<br />

Australia, include Chloé, Columbia Sportswear,<br />

Diane von Furstenberg, Dragon, Flexon, Lacoste,<br />

MCM, Nautica, Nike, Nine West and Salvatore<br />

Ferragamo.<br />

Marni, another of VSP’s new brands, was displayed<br />

at ODMA17’s Design Junction, a collection of small<br />

stands towards the back of the hall, designed to<br />

showcase high-end international and Australian<br />

eyewear brands. “Marni is a very special brand, a<br />

real architectural-type of frame…it’s amazing,” says<br />

Williams, but will only be suitable for practices<br />

aiming at a particular type of customer.<br />

DFV: Eye-Light for dry eye<br />

Designs for Vision’s team delightfully continued<br />

their tradition of dressing up for ODMA, with<br />

this year’s team members sporting red and black<br />

lumberjack shirts and some very unfetching<br />

mullets. Out in front of the stand, however, in a<br />

somewhat mullet-clashing, pale green colour, was<br />

a brand new device from the DFV stable, called the<br />

Eye-Light.<br />

Eye-Light is the latest intense pulsed light (IPL)<br />

device designed specifically to treat meibomian<br />

gland dysfunction (MGD). Unlike its older rivals<br />

– France Medical’s E>Eye and Lumenis’ M22, the<br />

latter promoted by the self-claimed founder of<br />

IPL for MGD, Dr Rolando Toyos, who was one<br />

of ODMA17’s keynote speakers – the Eye-Light<br />

is said to combine both optimal power energy<br />

(OPE) and low level light therapy enabling it to<br />

treat both upper and lower eyelids. According to<br />

the marketing material, it also doesn’t require<br />

any “messy gel” as it automatically detects skin<br />

type and manages pulse intensity via dedicated<br />

software. “By avoiding the use of gels, the OPE/IPL<br />

component of the treatment can be completed in<br />

less than five minutes… (and patients) experience<br />

positive results after the first session.”<br />

DFV general manager Brad Grills, modelling a<br />

particularly surfy-looking mullet, said the Eye-Light<br />

was also a cost effective alternative to its rivals<br />

and cost less to run. Dry eye was a particular focus<br />

for DFV at ODMA, he said, so he was pleased to<br />

showcase the latest in IPL technology, alongside<br />

the company’s other popular dry eye products,<br />

such as the the Oculus Keratograph 5M – an<br />

advanced corneal topographer with a built-in real<br />

keratometer and a colour camera, optimised for<br />

external imaging, for examining the meibomian<br />

glands, measuring tear film break-up time and tear<br />

meniscus height and evaluating the lipid layer.<br />

Optimed: ODMA winner<br />

A “very” chuffed Craig Norman from Optimed<br />

was proudly displaying a glass ODMA17 winner’s<br />

trophy for the company’s Eidon Truecolour<br />

ERO NZ Optics FP_<strong>2017</strong>.pdf 1 12/07/<strong>2017</strong> 8:28:03 AM<br />

Confocal Scanner by Centervue, which won the<br />

‘Optical instruments’ category. “In the diabetic<br />

screening field, the Eidon Confocal Scanner has<br />

been a very innovative and a very good product for<br />

fundus imaging,” he said.<br />

Another particular focus for the Optimed team<br />

at ODMA, however, was the new Revo NX, the<br />

world’s fastest OCT, which scans at a staggering<br />

110,000 A/scans per second. “It’s superfast speed<br />

allows the capture of detailed OCT angiographic<br />

images (OCT-A) simply,” said the company. “It’s<br />

fully-automated operation is so simple that<br />

anyone can use this device with just five minutes<br />

training. Featuring retinal, disc, ganglion, widefield,<br />

detailed cornea, pachymetry and angle-toangle<br />

scanning with the option of OCT-A, this OCT<br />

is a comprehensive diagnostic solution for your<br />


C<br />

M<br />

Y<br />

CM<br />

MY<br />

CY<br />

CMY<br />

K<br />

Style | THE VINTAGE<br />

AU & NZ Distribution<br />

look@clicproducts.com.au | ph +61 2 9969 5053<br />

www.cliceyewear.com.au<br />

NZ 0800 447 272<br />

12 NEW ZEALAND OPTICS <strong>Aug</strong>ust <strong>2017</strong><br />

Untitled-7 1<br />

12/07/<strong>2017</strong> 8:29:34 AM

Plus the chance<br />

to WIN gift card<br />

prizes^<br />

FREE Hoyalux iD lenses *<br />

During July – September <strong>2017</strong><br />

Buy 5 pairs of Hoyalux iD lenses (LifeStyle V+, Classic, MyStyle V+ or WorkStyle V+) with Diamond<br />

Finish, DF BlueControl or DF UV Control and receive your choice of 1 FREE pair of Hoyalux iD<br />

lenses with Diamond Finish, DF BlueControl or DF UV Control.<br />

Hoyalux iD individualised progressive lenses are designed to meet your patients’ specific needs.<br />

They provide clear, natural sight at all distances, wide distortion free fields of vision, superior image<br />

stability and a smooth transition between near and far. They are the perfect all-rounder option.<br />

Hoyalux iD WorkStyle V+ indoor lenses are specifically designed for patients who work in office<br />

environments, providing perfect vision for close distance activities. WorkStyle V+ lenses meet the<br />

needs of today’s modern lifestyle offering three lens designs – Space, Screen and Close.<br />

You and your practice staff also have the opportunity to WIN Coles Myer Gift Cards^!<br />

Register today to participate in this sales promotion and for further competition details^,<br />

visit www.hoyalens.com.au/iD17<br />

*<br />

Terms and Conditions: 1. Customers must be registered to participate in the sales promotion. 2. The promotion offer is valid on applicable Hoyalux iD (MyStyle V+, LifeStyle V+, Classic & WorkStyle V+ only) orders placed with Diamond Finish,<br />

Diamond Finish BlueControl or Diamond Finish UV Control between 1 July and 30 September <strong>2017</strong>. 3. The ‘5 pairs of Hoyalux iD lenses’ (listed above) must be bought within the same month, based on order date. 4. The free pair of Hoyalux<br />

iD lenses will be offered via Fast Track Credit within 14 days of receipt of your Redemption Sheet(s) by Hoya Marketing. 5. The free pair of Hoyalux iD lenses chosen must be clear and a 1.5 or 1.53 index lens. 6. The free pair can only be Hoyalux<br />

iD lenses. 7. The free lenses redeemed through this sales promotion are not counted towards purchases for the sales promotion. 8. This offer cannot be used in conjunction with any other offer. 9. The offer is not applicable on safety orders. 10.<br />

Participating practices must be within current trading terms. ^Competition: See www.hoyalens.com.au/iD17 for more details.<br />

<strong>Aug</strong>ust <strong>2017</strong><br />




Jono Hennessy’s colourful stand with Louise, Teiger and Jono Hennessy Sceats Inspecs’ Fiona Bermingham and Robert Morris of William Roz Sturt and Kristine O’Brien from Look for Life Hoya’s Stuart Whelan and Ulli Hentschel<br />

Morris’ fame<br />

practice.” It’s particularly good for tricky patients,<br />

such as kids, added Norman.<br />

Zeiss: a digital practice<br />

Zeiss’ impressive, high-tech ODMA stand was set<br />

up as if it was a real-life, state-of-the-art practice,<br />

featuring a number of completely new digital tools<br />

designed for today’s and tomorrow’s optometrists.<br />

It’s “all about embracing a digital life,” said<br />

Pamela Andrews, Zeiss’ marketing manager<br />

for consumer products, who walked NZ Optics’<br />

through the stand. At the “reception area”<br />

were iPads, with a new vision-profiling app to<br />

help patients select the best lens for their life<br />

whether they are in the practice or at home. This<br />

was followed by Zeiss’ latest screening tools,<br />

including wavefront analysis and measurement<br />

and refraction instruments, all of which are<br />

integrated with Zeiss’ Visuconsult platform,<br />

which can record all data directly and transfer<br />

it between instruments. Then came Zeiss’<br />

advanced diagnostics tools, including Forum,<br />

which offers “a scalable and flexible eye care data<br />

management solution”; the Zeiss VR One Plus, a<br />

new virtual reality (VR) tool allowing patients to<br />

really experience different spectacle solutions;<br />

and ending with Zeiss’ online ordering system,<br />

Visustore, which is also fully integrated with<br />

Visuconsult so no data needs to be re-entered.<br />

“We’ve got so many digital tools coming out,<br />

giving practices so many options, it’s very exciting,”<br />

said Andrews. “At the end of the day we just want<br />

the consumer to get the best information they can<br />

to make the best decision they can for their eye<br />

health and lifestyle, and we hope that will include<br />

a Zeiss lens. So we’re getting people to think<br />

more about the fact that there are lots of aspects<br />

that go into deciding what type of lens is best for<br />

somebody. It makes such a huge difference.”<br />

In a consumer marketing move, Zeiss is also<br />

reaching out to bloggers on both sides of the ditch<br />

to help them better understand the importance of<br />

choosing the right lens, which should help build<br />

awareness among consumers about lens choice,<br />

she added.<br />

Modstyle: Eclipse<br />

With its fashion brand Avanti doing well in New<br />

Zealand after the first shipment arrived on our<br />

shores in March, Modstyle managing director Mark<br />

Wymond was keen to talk about the company’s<br />

second signature brand, Eclipse, which is also now<br />

available in New Zealand through CMI Optical.<br />

Made from high-quality stainless steel, nylon<br />

and titanium, Modstyle’s Eclipse brand has finally<br />

come of age, said Wymond, with the brand’s range<br />

tripling in size in the last few months. “We now<br />

have about 13 trays, with a lot of titanium and<br />

some hand-painted work through the top of the<br />

frames.” The new range has been very well received<br />

in Australia, so should complement Avanti in New<br />

Zealand, he said.<br />

Wymond, son of Eyes Right Optical’s founders’<br />

Gaye and David Wymond, bought Modstyle late<br />

last year. Modstyle’s brands are not competitive<br />

to Eyes Right’s as they are more towards the<br />

budget end of the market, though they are still<br />

manufactured to a high standard, mainly in Korea,<br />

and incorporate quality details like European<br />

spring hinges, he said. Prices are kept low as they<br />

are designed primarily in-house, which is very<br />

satisfying, he said, and shipped directly from the<br />

factory to Australia.<br />

Wymond had recently returned from visiting the<br />

company’s Korean factory partners and was “very<br />

impressed,” he said. “It was a buying trip, but we<br />

also wanted to check the factories were doing the<br />

right thing. We found the Korean manufacturing<br />

process to be very clean and ethical. Koreans are<br />

paid on average 20% higher than anywhere else in<br />

Asia. They do all the metal work, have very good<br />

standards and long-term employees who really<br />

know what they are doing.”<br />

Also on display, and new to Modstyle, was the<br />

company’s affordable Kaleyedoscope range for kids<br />

made from very colourful multi-layered acetate.<br />

Dynamic Eyewear: Nicola Finetti<br />

Basing themselves on Tiger Vision’s stand, the<br />

team from Dynamic Eyewear were proudly<br />

introducing ODMA visitors to Tony Ghosen, Tiger<br />

Vision’s head designer for Wayne Cooper and<br />

Nicola Finetti eyewear, who won the ODMA17<br />

Excellence award in the ‘Optical frames – women’<br />

category, for Nicola Finetti model nf819 (pictured).<br />

The new Nicola Finetti range is a combination of<br />

metals and acetates, all good quality but at a really<br />

affordable price, making them very attractive,”<br />

said Dynamic’s Paul Beswick. The award’s great<br />

recognition for Finetti’s eyewear collection,<br />

especially as Ghosen’s frame choice was up against<br />

European brands such as Face á Face and Joop,<br />

he said. “I have a passion for glasses and being<br />

recognised for it is just the icing on the cake,”<br />

added a smiling Ghosen.<br />

Also attracting attention on the Tiger stand was<br />

the new Wayne Cooper women’s eyewear collection<br />

‘Bohème’, which Dynamic is introducing to New<br />

Zealand this month (see separate story, p4).<br />

Modstyle’s Mark Wymond<br />

Optique Line: Stepper Eyewear<br />

Optique Line’s busy stand was divided in two, with<br />

one half focusing on Optique Line’s house brands,<br />

such as its popular Mersey Beat range launched<br />

last year at ODMA’s first boutique ‘O-Show’ fair,<br />

and the other side focusing on the well-known,<br />

popular German brand Stepper.<br />

A particular drawcard for the Stepper stand was<br />

German founder, optometrist and co-designer<br />

Hans Stepper himself. Stepper has been designing<br />

and manufacturing innovative and technicallyintelligent<br />

frames for more than 40 years, each<br />

guaranteed to fit properly and be comfortable to<br />

wear. Patented TX5 polyamide and titanium, which<br />

is light, flexible and strong, are used extensively<br />

throughout the range.<br />

Talking to NZ Optics, Stepper said he was very<br />

happy to be back in Australia for ODMA17. He<br />

set up Stepper in 1970 with an expert in plastic<br />

moulding technology after being frustrated about<br />

the poor quality and fit of frames in the market<br />

back then. The frames have always been particularly<br />

successful and popular in Anglo-Saxon countries<br />

like England, the US, Canada, Australia and New<br />

Zealand; and Brazil, he laughed, as the company has<br />

a very good distributor in Brazil. The company is also<br />

attracting a younger demographic after introducing<br />

the Stepper-S brand, designed and marketed by<br />

Stepper’s daughter, Saskia. It is also the worldwide<br />

licence holder for Zeiss eyewear.<br />

Hoya + You and Oliver Woolf, and more<br />

Depicted by attractive black and white images of<br />

musicians playing duets, Hoya’s main message for<br />

visitors to ODMA17 was “Hoya and you.”<br />

“The duet signifies playing together. Together<br />


Distributed by<br />

09 482 3250<br />

quarter Page JONO ad.indd 1<br />

14 NEW ZEALAND OPTICS <strong>Aug</strong>ust <strong>2017</strong><br />

4/07/<strong>2017</strong> 1:22 PM<br />

Untitled-8 1<br />

12/07/<strong>2017</strong> 8:54:04 AM



©<strong>2017</strong> DRAGON ALLIANCE INC.<br />

Dragon’s line of premium eyewear brings athletic inspiration and innovation<br />

together to make top quality products with a youthful, fashion forward twist.<br />

The new Dragon optical collection aims to capture a younger audience with<br />

a deep passion for exploration and adventure.<br />

p: Toll Free 1800 251 025<br />

e: customerservice@vspaustralia.co.nz<br />

w: www.vspaustralia.co.nz<br />

<strong>Aug</strong>ust <strong>2017</strong> NEW ZEALAND OPTICS<br />



Phoenix Eyewear’s Peter Nicholls, Mark Collman and Bill Devereaux Zeiss’ Pamela Andrews BTP’s Caron Bowe and Trish Orr with De Rigo’s Vittorio Trusso Vivid Vision’s Brian Dornbos and Tuan Tran Clic’s new range<br />

we’re more powerful,” explained Ulli Hentschel,<br />

Hoya’s national training and development<br />

manager. It’s also to show how committed Hoya<br />

is to its customers, he said, to emphasise in-lightof<br />

the Essilor-Luxottica merger that Hoya’s not<br />

interested in retail, “that we will be there to really<br />

support the independent market.”<br />

To help facilitate that, Hoya is launching a new<br />

eyewear collection called Oliver Wolfe Design, he<br />

said. “We’ve partnered with a frame manufacture<br />

to deliver this… (so) we can deliver an eyewear<br />

collection at a price you wouldn’t normally be able<br />

to get for the quality of the goods.”<br />

According to Hoya, Oliver Woolfe was “inspired<br />

by practice requests.” The brief was for a youthful,<br />

contemporary frame range at a mid-range price<br />

point, that’s easy to order from Hoya. The frames<br />

will retail for about $180 to $200 in New Zealand,<br />

“with a very good margin,” for practices, said<br />

Hentschel. “From our perspective, it’s not about<br />

us having eyewear as a profit centre, it’s really a<br />

tool to help our customers compete against larger<br />

corporates and online retailers.” As a verticallyintegrated<br />

stock, it’s also about efficient supply<br />

chain management, allowing Hoya to fit the<br />

frames and lenses in-house after the patient has<br />

selected their look in the practice.<br />

Hoya was having an ODMA launch frenzy, not<br />

only introducing Hoya + You and Oliver Wolfe to<br />

the market, but also unveiling its new driving lens,<br />

Enroute, its new sport and fashion performance<br />

lens, Sportive, and its new virtual reality (VR)<br />

offering, Vision Simulator.<br />

Enroute lenses are designed for a person who<br />

loves to drive or drives a lot’s second pair of<br />

glasses, said Hentschel. They come in single and<br />

progressive, and there’s also a pro version, Enroute<br />

Pro, for professional drivers, combining Enroute’s<br />

glare filter and optional contrast-enhancing filter<br />

with a further optimised-lens design for the<br />

viewing distance to the dashboard and mirrors,<br />

tailored to the driver’s posture.<br />

New Zealand’s Stuart Whelan was particularly<br />

excited about being able to introduce outdoor mad-<br />

Kiwis to Hoya’s Sportive lens, designed to provide<br />

good optics and high-contrast vision in all weather<br />

conditions across a full-wrap frame. The lenses are<br />

available in single and progressive design and come<br />

polarised and photochromic. “Before Sportive, it<br />

was always a compromise,” said Whelan, but now<br />

Hoya can provide full vision to anyone, whatever<br />

their outside lifestyle or sport choice.<br />

Previewed at the O-Show, Hoya’s award-winning<br />

Vision Simulator is now available to purchase in<br />

New Zealand and was attracting a lot of interest at<br />

ODMA. Using a customer’s actual prescription, the<br />

simulator enables a practice to provide “a highly<br />

accurate, 3D representation of the optical effects<br />

of various lens designs and treatments… giving<br />

your customers the opportunity to choose the<br />

options that work best for them.”<br />

France Medical: Vivid Vision<br />

Taking pride of place on the France Medical stand<br />

was Vivid Vision’s new virtual reality solution<br />

for strabismus, amblyopia and convergence<br />

insufficiency. Aimed at both adults and children,<br />

the VR device allows you to play games by literally<br />

waving your arms in the air, poking VR bubbles,<br />

flying VR spaceships through hoops and a host of<br />

other things, all of them fun.<br />

Patches simply don’t work for the majority of lazy<br />

eye patients and kids hate wearing them, said Vivid<br />

Vision’s Brian Dornbos, who was there with his<br />

optometrist colleague, Tuan Tran, to help promote<br />

Vivid Vision to ODMA visitors. “We can help patients<br />

develop depth perception. It works across all forms<br />

of amblyopia. Patients just have to play games. They<br />

don’t even know they are being treated.”<br />

In a study published in BMC Ophthalmology in<br />

May this year, Vivid Vision’s effect on 17 patients (10<br />

men and seven women, ranging from 17 to 69 years<br />

old) with anisometropic amblyopia was evaluated.<br />

After eight sessions, the mean best corrected<br />

visual acuity (BCVA) improved significantly from<br />

a logMAR value of 0.58 ± 0.35 before training to a<br />

post-training value of 0.43 ± 0.38 (p < 0.01), with<br />

47% of participants achieving a BCVA of 20/40 or<br />

better, compared with 30% before the training. The<br />

study was deemed a success, but researchers said<br />

further clinical trials were needed to confirm “this<br />

preliminary evidence”.<br />

Dornbos said patients only need to come into a<br />

Vivid Vision: bursting bubbles in VR to combat ambylopia<br />

practice to “play games” once a week, for a few<br />

months, though this can be up to a year for more<br />

severe cases. The company is also launching a<br />

home-based version in the US, which should also<br />

be available here before the end of the year.<br />

Clic<br />

The Clic stand was attracting quite a bit of attention<br />

at ODMA with the brand’s new range of magnetic<br />

reading sunglasses. Clic’s Helen Najar said sales were<br />

going very well, with the brand’s vintage round and<br />

panto-shaped styles for men proving particularly<br />

popular, plus the company’s aviator-style sunnies.<br />

Christchurch optometrist John Veale admitted to<br />

being a fan, adding that actually wearing his Clic’s in<br />

his practice brings them alive for patients, who can<br />

then see how useful they really are!<br />

Device Technologies: Captiv8<br />

UK optometrist Dr Trusit Dave was sharing Device<br />

Technologies’ stand to help explain and promote<br />

his patient engagement and marketing platform,<br />

Captiv8.<br />

The new tool, distributed by Device in this part<br />

of the world, allows optometrists to show patients<br />

clever 3D animations about their condition, however<br />

complex, explaining what’s going on in pictures<br />

rather than words. The animations, branded with<br />

the practice’s own logo, can be used in the practice<br />

or sent via email or text to a patient so they can<br />

view and share them. The animations can also be<br />

used and shared online through social marketing<br />

platforms to draw potential patients into a practice<br />

and to respond to discussions, for example on twitter.<br />

Captiv8 also monitors twitter feeds so a practice can<br />


▶ optomap ® imaging takes less than half a second<br />

to help prevent vision loss<br />

the ONLY 200° single-capture retinal image<br />

optomap non-mydriatic ultra-widefield technology<br />

delivers detailed 200º high resolution images in less than<br />

half a second. This technology can image pathology<br />

past the vortex vessels, helping you find disease sooner<br />

and treat it more effectively. optomap is a powerful tool<br />

in the fight against vision loss.<br />

Contact us to find out more about finance opportunities<br />

at +61 8444 6500 or auinfo@optos.com<br />

©<strong>2017</strong> Optos. All rights reserved. Optos ® , optos ® Daytona and optomap ® are registered trademarks of Optos plc. GA-00315 /1<br />

16 NEW ZEALAND OPTICS <strong>Aug</strong>ust <strong>2017</strong>

ODMA17 Excellence Awards<br />

The ODMA Awards of Excellence aim to reward<br />

the best in fashion, innovation and technology<br />

at the show. Entries are submitted by exhibitors<br />

and are judged by an independent panel<br />

including, ODMA CEO Finola Carey and industry<br />

members Professor Fiona Stapleton, Grant<br />

Hannaford and Peter Hewett.<br />

The Excellence Awards and best stand winners<br />

for <strong>2017</strong> are:<br />

Captiv8’s Dr Trusit Dave and Device’s Campbell Gordon Face a Face’s Pascal Jaulent Von-Arkel’s award winning display case VSP’s somewhat distracting Calvin Klein models<br />

respond when and if a discussion on eye health is<br />

happening in their catchment area.<br />

The best way for any practice to gain new<br />

customers is word-of-mouth, said Dr Dave and<br />

from a digital marketing standpoint, social<br />

media is the perfect modality to increase<br />

recommendation. Plus, the more engaging your<br />

posts, the more likely the reader will be to share<br />

them, thus recommending the practice, he<br />

explained.<br />

Eyes Right Optical: Face á Face<br />

Excellence Awards’ finalist, Face a Face’s Yokko<br />

Eyes Right Optical’s large stand was very busy, but<br />

attracting particular attention was Face á Face’s<br />

co-founder and designer Pascal Jaulent, who was<br />

running daily presentations on the stand about what<br />

drives Face á Face’s colourful and expressive designs.<br />

“Bonjour… I love eyewear because it’s human,<br />

technical, medical, fashionable, design-full. All<br />

this, united together, makes it so exciting and our<br />

common passion,” explained Jaulent.<br />

Face á Face’s latest collection, he said, was<br />

inspired by his love of architecture. “It incorporates<br />

modern architectural and fashionable trends,<br />

exquisite colour combinations and original,<br />

contrasting aspects and materials… made<br />

with exclusive acetate structures, playing with<br />

transparency and light to express seduction,<br />

femininity, harmony and, importantly, strength.”<br />

Known for its clever use of colour, for Face á<br />

Face today “green is the new black”, influenced by<br />

natural materials, such as stone, with many now<br />

incorporating gold details, said Jaulent.<br />

He also mentioned his love of surrealism, hence<br />

the company’s playful Bocca range, famed for its<br />

lady’s leg and shoe temples. “It’s iconic for the<br />

collection, and every season I work on a different<br />

expression… so every type of woman will find her<br />

personal collection within my collection.”<br />

For men, Jaulent highlighted the company’s use<br />

of aluminium, a very light material, but difficult to<br />

work with, but appealing to men because of the<br />

technology involved and the performance of the<br />

frames. To reduce the “coldness” of the aluminium,<br />

the surface is sandblasted, he said.<br />

William Morris Black Label<br />

The wonderful Robert Morris of iconic British<br />

brand William Morris was as busy as usual. Helping<br />

him promote his new ranges, however, were<br />

Phoenix Eyewear’s Peter Nicholls, Mark Collman<br />

From the Black Label range<br />

and Bill Devereaux who were over at ODMA to visit<br />

a number of their suppliers.<br />

On the William Morris’ stand, attracting particular<br />

interest was William Morris’ Black Label range,<br />

said Collman. The luxurious range, for the more<br />

adventurous is a little more vintage, a little darker,<br />

featuring bolder shapes and colours and classic<br />

combinations of metal and acetate, he said. “Now is<br />

really the right time to showcase these more retro,<br />

timeless styles. They are selling really well.”<br />

Optos: Daytona Plus<br />

Optos’ Jason Martone and the new, colourful Daytona Plus<br />

Combining beauty and functionality, the new<br />

Daytona Plus ultra-widefield (UWF) imaging<br />

system is the next generation in widefield retinal<br />

imaging, said Optos managing director, Jason<br />

Martone. The much-smaller, more compact device<br />

still provides digital images of 200 degrees, or<br />

up to 82% of the retina, in a single, non-contact<br />

optomap image, but also incorporates new<br />

OptosAdvance browser-based image review<br />

software, simplifying documentation, monitoring<br />

and referral processing for better patient<br />

management and improved patient flow.<br />

The new generation of Optos UWF imaging tools<br />

was unveiled at ODMA17 and is available in black<br />

with red trim, white with red trim or the more<br />

conventional white with silver trim. It’s attracting a<br />

lot of interest, said Martone, with many surprised<br />

at the product’s compact size. “It’s really a product<br />

for everyone… and the software sits on the server<br />

so can be accessed throughout a practice.”<br />

Jono Hennessy: Volte Face<br />

Occupying a few stands at ODMA’s Design<br />

Junction, Jono Hennessy and his Carter Bond and<br />

Zeffer ranges were accompanied by a number of<br />

independent European brands the Australiandesigner<br />

company has taken under its wing,<br />

including: Kaleos (Spain), Louis (Belgium), Simple<br />

(France) and Adrian Marwitz (Germany). The latest<br />

brand to join this independent-family group,<br />

however, was elegant, eye-catching French brand<br />

Volte Face designed by Fabienne-Coudray Meisel.<br />

All are up-and-coming, independent designers<br />

who are passionate about what they do, but need<br />

representation over here, said Jono Hennessy’s<br />

managing director and partner Louise Sceats.<br />

“Volte Face is the last one to come into, what<br />

we call, our ‘Stars of independence’ and so we’re<br />

launching it at ODMA… and everyone is loving it.<br />

It’s interesting, it’s out there and it fits with our<br />

brands. We’re all on the same wavelength.”<br />

By coming together, Jono Hennessy is able<br />

to offer independent practices real choice,<br />

from people like them; people who believe in<br />

independence and family businesses, said Sceats.<br />

“It’s actually strengthened the Jono Hennessy<br />

Group because we can now be a one-stop shop for<br />

people looking for independent brands.”<br />

More practically, by working with other brands,<br />

the time delays between design and delivery for<br />

Jono Hennessy’s “fabulous” ranges can be filled with<br />

other brands, so there’s constantly new product<br />

coming through, added Jono Hennessy Sceats.<br />

See more from ODMA17 in next month’s NZ Optics<br />

Optical frames, men: Healy Optical – Lafont,<br />

mod: 500B1 (pictured)<br />

Optical frames, women: Tiger Vision – Nicola<br />

Finetti, mod: NF819<br />

Sunglasses: Noo Eyewear – Meteor, Masunaga by<br />

Kenso Takada<br />

Children’s frames: European Eyewear – Titanflex<br />

Kids, mod: 830076 30 41-22<br />

Lens design: Essilor – Special Lenses<br />

Lens coating: Rodenstock – Solitair Red Sun<br />

Optical instruments: Optimed – Eidon:<br />

Truecolour Confocal Scanner<br />

Accessories: Hilco – Leader Rx-able swim googles<br />

Product environment (pos, retail): MYM Group –<br />

Von Arkel, 18-unit display case<br />

Best stand over 54sqm: De Rigo Vision Australia<br />

Best stand under 54sqm: Stepper Eyewear<br />

Australia<br />

Best shell scheme stand under 18 sqm: Special<br />

Agent<br />


Proudly supplying NEW ZEALAND<br />

OPTOMETRISTS with exclusive digital<br />

lens designs, quality and service!<br />

www.shamir.co.nz | info@shamirlens.com.au<br />

<strong>Aug</strong>ust <strong>2017</strong><br />



Focus<br />

on Business<br />

Becoming the community<br />

cornerstone…<br />

Spotting the unusual…<br />


Richard Johnson, Debra So and Jason Dhana<br />

Philip Walsh and Malcolm Lowrey<br />

Ming Wang and Tracy Thompson<br />

Offering more for locals: yoga at a Lululemon store in Auckland<br />

One of the typical challenges in<br />

the development of a retailer’s<br />

network is how you can bring<br />

to life your brand proposition in a<br />

consistent way that serves as a beacon<br />

to shoppers, that is not only effective<br />

and cost efficient, but engaging to the<br />

local catchment?<br />

In my time as a retailer, and<br />

especially in a marketing capacity,<br />

there is a huge tension in getting the<br />

economies of scale possible from a<br />

brand experience vs injecting new,<br />

local, personality and communityconnections<br />

into bricks and mortar<br />

environments.<br />

What we do know is that smaller,<br />

individual retail businesses can build<br />

incredibly powerful (and profitable)<br />

propositions from highly-personalised<br />

service; being recognised “as a local”;<br />

and having their finger on the pulse<br />

to build localised-product ranges.<br />

What lessons we take from that is the<br />

successful retailer’s ability to adapt,<br />

tailor and keep their ear to the ground<br />

to best connect with the heart and<br />

soul of their community!<br />

The retail store is the single, mostimportant<br />

manifestation of a business’<br />

brand and retail proposition. It brings<br />

to life the idea, purpose, reason-forbeing<br />

and the environment to build<br />

relationships. It is the concept that<br />

shoppers are buying into when they<br />

choose a store and, often, it’s that<br />

brand relationship that they take<br />

beyond.<br />

A key, recognised trend in retail is<br />

becoming a ‘community cornerstone’.<br />

An idea whereby retailers are bringing<br />

their core set of values to life in a<br />

way that connects with their local<br />

community.<br />

One example of this concept<br />

executed well, is Canadian lifestyle<br />

brand Lululemon’s newest store in<br />

Bondi Beach, Sydney. The shop acts as a<br />

community hub to facilitate connection<br />

and conversation with innovators,<br />

creators and water-obsessed, sweaty<br />

enthusiasts. This smaller, hyper-local<br />

store celebrates the iconic beauty and<br />

active lifestyle of the area. Custom<br />

work by a local artist is the focal point<br />

of the store with two large murals<br />

which span the dedicated community<br />

space – an ideal environment for<br />

meetings, co-working and connection.<br />

Lululemon stores in New Zealand are<br />

doing similar things by, for example,<br />

running yoga classes in their stores.<br />

What makes a store experience<br />

local?<br />

It is never just one thing, but rather a<br />

combination of factors and emotions<br />

that lead customers to connect with<br />

a particular store. That means that<br />

retailers need to offer more than just<br />

a place to buy stuff. They need to offer<br />

a space to interact and transact in<br />

culture, experiences and relationships.<br />

This requires a whole lot of different<br />

thinking in order to learn how to ‘be<br />

the hub.’ Just having a “Hello” on the<br />

wall or a picture of a mountain won’t<br />

be enough!<br />

Knowing and respecting the<br />

environment you’re in and the<br />

concerns of your customers by giving<br />

back to the community, ultimately<br />

builds a stronger sense of loyalty and<br />

pride for the consumer towards the<br />

retailer.<br />

Loblaws, a Canadian-based grocery<br />

chain, has a strong community of<br />

people wanting to become healthier<br />

attending their daily nutrition classes;<br />

a natural extension to its offering.<br />

As we see more and more shoppers,<br />

especially millennials, valuing<br />

experiences over simply buying stuff,<br />

and wanting to know more about<br />

and participate in the development<br />

of a product, it is time more retailers<br />

started to consider what role they can<br />

play within their communities and<br />

what would make a real difference to<br />

their shoppers. Being a community<br />

cornerstone could ultimately be the<br />

difference in defining your store from<br />

the competition, and building a brand<br />

that has meaning and a business that<br />

is profitable. ▀<br />


*Juanita Neville-<br />

Te Rito, is the<br />

founder of<br />

retail specialist<br />

consultancy,<br />

The Retail<br />

Collective.<br />

With more<br />

than 25 years’<br />

experience in<br />

the industry<br />

and a personal<br />

passion for<br />

shopping, she is<br />

full of insights<br />

that can transform the brand experience<br />

provided by retailers at every level. For more<br />

information contact Juanita on +64 274 768<br />

073 or juanita@theretailcollective.co.nz.<br />

Eye Institute’s <strong>2017</strong> seminar series kicked off in style at the<br />

Ellerslie Convention Centre in Auckland, in May with a<br />

good turnout, despite the weather, substantial canapé’s<br />

and a good selection of wines (this writer was pleased to see<br />

chardonnay back on the menu).<br />

The new world of trifocal IOLs<br />

Dr Nick Mantell kicked off proceedings with an overview about<br />

the different trifocal intraocular lenses (IOLs) available today<br />

and how best to manage patients after surgery.<br />

The advantage of trifocal lenses over bifocal IOLs are less halos,<br />

improved contrast sensitivity and far better vision range. They<br />

are becoming increasingly popular as baby boomers move into<br />

the cataract age range and have a better understanding of the<br />

choices available. But penetration is still low (3% in the US). Postoperative<br />

care is the same as for monofocals, said Dr Mantell,<br />

but patients do require regular care to ensure their vision and<br />

comfort is optimised. Optometrists should particularly check<br />

refraction, tear film, IOL centration, posterior capsular and<br />

vitreous opacity and the macula. “These are high performance<br />

lenses and there is no doubt they give patients the best range of<br />

vision available…despite this, many patients would still benefit<br />

from glasses for some tasks.”<br />

Glaucoma: mistakes, lies, lessons<br />

Contrary to belief, glaucoma patients do suffer symptoms<br />

before glaucoma is fully evident; symptoms that affect not<br />

just them, but those around them, said Professor Helen<br />

Danesh-Meyer. Early sufferers have a three-times greater risk<br />

of being involved in driving accidents (worse if they are men)<br />

and a far higher incidence of falls. Key is ensuring patients<br />

understand this, have realistic expectations and understand<br />

the importance of compliance when it comes to taking their<br />

medication. Studies show 98% of patients say they take their<br />

glaucoma drops when and how they should, but only 67%<br />

actually do. Patients often fail to comply for obscure reasons<br />

such as finding the bottle too hard to squeeze or simply failing<br />

to put the drops in properly, said Prof Danesh-Meyer. “It’s not<br />

just defiance from the patient, it’s a much more complex than<br />

that.” Optometrists and ophthalmologists need to work closely<br />

together to solve compliance issues, she said.<br />

Equally important is measuring a patient’s corneal thickness<br />

to create a baseline allowing better assessment of ocular<br />

hypertension and thus the onset and progression of glaucoma,<br />

she added. “Treating ocular hypertension is all about treating<br />

risk and if you look at the risk factors for converting to<br />

glaucoma, there is none more powerful than corneal thickness<br />

in predicting who is likely to go on to develop glaucoma.”<br />

Later in the evening Dr Simon Dean also tackled the<br />

somewhat “fluffy” subject of glaucoma, outlining the<br />

importance of using optical coherence tomography (OCT) and<br />

how best to use it to determine if glaucoma is present and<br />

is progressive, so should be treated. The best way to identify<br />

and monitor glaucoma is to monitor changes to pressure and<br />

corneal thickness over time. Ideally baseline tests should be<br />

taken around 40 to 45 years of age to ensure early diagnosis as<br />

any vision loss from glaucoma cannot be recovered, he said.<br />

Congenital ptosis and “watery eyes”<br />

Dr Dean revisited his RANZCO NZ conference talk on congenital<br />

ptosis and how best to talk to a patient’s parents about what<br />

they can expect, the importance of waiting and managing<br />

expectations. Ptosis is associated with a congenital weakness<br />

Ilana Gutnik and Dr Marcy Tong<br />

Robert Ng, Tina Gao and Ayah Hadi<br />

of the levator palpebrae superioris and treatment is based on<br />

vision, not on cosmetic requirements while patients are young,<br />

he said. As children get older there is the possibility they can<br />

outgrow the “look of their ptosis” so can avoid the need for<br />

surgery all together, he said. Margin reflex distance is the best<br />

thing to measure for ptosis and if the lid covers the pupil then<br />

surgery should be considered.<br />

Dr Peter Ring discussed “watery eyes” (ephiphora) and<br />

when tearing is a sign of something more worrying. Key to<br />

understanding what is causing watery eyes, is taking a detailed<br />

patient history: does it feel like “true tears”, when and where<br />

does it happen, is it intermittent or constant, do they suffer<br />

from allergies, are they on any medication, have they had<br />

any previous facial surgery or ocular infections and do they<br />

have any associated symptoms like photophobia, itchiness<br />

or blurring. Treatments vary according to cause, with surgery<br />

required for conditions such trichiasis or entropion.<br />

Preventing acute hydrops<br />

Acute corneal hydrops occur in approximately 3% of cases<br />

of keratoconus due to tears in Descemet’s membrane, said<br />

Professor Charles McGhee. It typically settles within 12<br />

weeks but the pathophysiology is poorly understood and it<br />

may produce significant corneal scarring leading to visual<br />

impairment and keratoplasty.<br />

In a New Zealand study assessing “the predisposing factors<br />

in acute hydrops in keratoconus” in 2012, the average age<br />

was found to be 24.6 years, with men having a slightly higher<br />

incidence than women. What was “unbelievable”, however,<br />

was the far higher incidence among Maori (25%) and Pacific<br />

people (54%). “Almost 80% of patients who get acute hydrops<br />

are Maori-Pacifica, so there must be a genetic element,” said<br />

Prof McGhee. There was also an association with “rubbing” and<br />

neglect, with 50% having never seen an eye professional before.<br />

It is a rare complication, that can come on very rapidly.<br />

Prevention is better than cure as the patients will develop<br />

severe corneal scarring and neovascularisation if not dealt<br />

with, thus subsequent keratoplasty does poorly. Ideally, if you<br />

see hydrops in the acute phase, topical antibiotics should be<br />

administered, especially if there are any signs of staining or<br />

epithelial defect, he warned.<br />

Foreign body removal and a quiz<br />

Given Kiwi’s penchant for DIY, removing “foreign bodies” from<br />

the eye isn’t a rare occurrence, said Dr Adam Watson, and with<br />

the right tool and a bit of experience, there’s no reason why<br />

optometrists can’t deal with most of these cases themselves.<br />

The whole eye, including the sclera and under the lid, needs to<br />

be checked thoroughly as a foreign body could have entered<br />

anywhere; patients should be referred for an x-ray or CT-scan<br />

if the history is suggestive, but nothing is found; and organic<br />

matter increases the risk of infection. Management includes<br />

monitoring vision, further examinations and topical anaesthetic,<br />

which also makes patients easier to examine. Rust rings are<br />

usually straightforward to remove with a needle, demonstrated<br />

Dr Watson, and it’s okay to leave a little staining in the cornea.<br />

Patients should be referred if the foreign body is vision threating,<br />

deep or has caused corneal lacerations.<br />

The evening was brought to a close with a light-hearted<br />

quiz conducted by Dr Peter Hadden on peripheral retinal<br />

degenerations; the weird, the wonderful, the sight-threatening<br />

and the completely harmless. ▀<br />

Professor Helen Danesh Meyer and Geoff Parker<br />

Linda Lin, Vaishna Singavarothayan, Devashini Devanandan and Radha Soma<br />

Karen Gardner and Teresa Hsu<br />

Dr Nick Mantell, Kerry Atkinson and Anne Durrant<br />

18 NEW ZEALAND OPTICS <strong>Aug</strong>ust <strong>2017</strong>

Beatling about at BCLA<br />


I<br />

recently had the privilege of attending the 40th British Contact<br />

Lens Association’s (BCLA’s) conference in Liverpool.<br />

Liverpool is a great place for a conference, especially if you’re a<br />

Beatles fan as their presence is everywhere.<br />

I must say it was, “A hard day’s night” as you always learn<br />

how much you don’t know about a subject when you attend an<br />

international conference, especially one celebrating 40 years of<br />

history, like BCLA was this year.<br />

I also have a bit of personal Beatles’ history having worked for<br />

British contact lens legend, John de Carle in 1972, whose Mayfair<br />

practice, at 74 New Bond Street in central London, sat below EMI’s<br />

first studio, where the Beatles’ first studio LP, ‘Please, Please Me’<br />

was recorded. John Lennon wore PMMA (polymethylmethacrylate)<br />

contact lenses, but was very poor at removing them at night, so had<br />

nasty over-wearing problems. It was John de Carle who suggested<br />

and sorted out the round, wire-framed National Health specs for him,<br />

giving him the iconic look everyone now remembers, and making<br />

sure “John Lennon” specs went from cheap to trendy for ever more!<br />

John de Carle was the first president of BCLA and invented the<br />

Permalens, the first extended-wear soft lens, with 70% water<br />

content. I had to wear them, of course. I called in to see my<br />

colleagues at Berkeley Optometry School on my way back to New<br />

Zealand and Professor Ken Polse did some tests on the thickness of<br />

my corneas after sleeping in the lenses and was surprised there was<br />

no overnight swelling. I remember having to keep one eye occluded<br />

after I woke up, so they could check each eye!<br />

Dry eye at BCLA<br />

This year’s BCLA conference was held at the Liverpool conference<br />

venue on the banks of the Mersey River where the beautiful old docks<br />

have been, and are continuing to be, upgraded to house shops, hotels<br />

and apartments.<br />

There were 1100 delegates representing all the world’s continents,<br />

except Antarctica, and 38 exhibitors. The focus was dry eye.<br />

Unsurprisingly therefore,<br />

our own Associate Professor<br />

Jennifer Craig was one of<br />

the main keynote speakers<br />

presenting, among other<br />

things, the just released<br />

Tear Film & Ocular Surface<br />

Society (TFOS) Dry Eye<br />

Workshop II (DEWSII) report.<br />

It’s worth reading as it has<br />

redefined dry eye disease:<br />

“Dry eye is a multifactorial<br />

disease of the ocular surface<br />

characterised by a loss of<br />

homeostasis of the tear<br />

film, and accompanied<br />

by ocular symptoms,<br />

in which tear film<br />

John Veale and Paul Rose at BCLA <strong>2017</strong><br />

instability and hyperosmolarity, ocular<br />

surface inflammation and damage, and<br />

neurosensory abnormalities play etiological<br />

roles.”<br />

Whew! That’s quite a definition. TFOS<br />

DEWSII then classifies the factors involved<br />

with dry eye, all of which is covered in<br />

detail in The Ocular Surface journal’s July<br />

issue (see story next month).<br />

The stage in the main auditorium at BCLA<br />

came equipped with a slit lamp, which was<br />

hooked up to the big screen so everyone<br />

could see what was happening. Jennifer<br />

then demonstrated various diagnostic<br />

tests and also covered some of the dos and<br />

don’ts of blepharitis management. These<br />

tutorials were really well received.<br />

I learnt about lid wiper epitheliopathy,<br />

the role of eyelid bacteria, lid-parallel<br />

conjunctival folds and more.<br />

Ortho-k<br />

Another key subject was orthokeratology (ortho-k). Former Sydneybased<br />

Brien Holden Vision Institute project director Dr Jennifer Choo<br />

ran a workshop with our own Paul Rose on ‘Are soft lenses a viable<br />

option for the irregular cornea?’ which was well attended. Dr Choo<br />

is now manager, global specialty lenses with Menicon in Canada,<br />

the internationally renowned Japanese contact lens manufacturer,<br />

which makes and distributes the Rose-K family of specialty lenses<br />

developed by Paul.<br />

Introducing MyDay ® toric<br />

In conclusion<br />

Another interesting lecture focused on how monovision for<br />

presbyopes may be unethical due to the fact we have good multifocal<br />

lenses for presbyopes now, which led me to think just how much we<br />

have progressed since John de Carle’s inaugural lecture forty years<br />

ago on the new bifocal soft contact lens he was designing.<br />

I can’t wait to see what the next 40 years brings. ▀<br />

*John Veale is a well-known low vision champion and optometrist based in<br />

Christchurch<br />

The toric design<br />

you know and love.<br />

Now smarter *<br />

A/Prof Jennifer Craig demonstrating blepharitis management in front of the BCLA’s 1000 plus audience<br />

Michael Holmes<br />

wins again<br />

Michael Holmes<br />

Premium<br />

Eyewear has<br />

retained its title of<br />

‘Retailer of the year’ in the<br />

<strong>2017</strong> Newmarket Business<br />

Awards. This is the third<br />

time the Newmarket<br />

optometrist has won the<br />

award, having first won<br />

it in 2012, then again in<br />

2016. Michael Holmes<br />

says he’s “thrilled” to have<br />

won again.<br />

Now in their sixth year,<br />

the Newmarket Business<br />

Awards celebrate local<br />

business excellence,<br />

recognising businesses<br />

Michael Holmes, ‘Retailer of the year’<br />

which are maximising their<br />

potential and have mastered the art of delivering excellent services<br />

and products in the Newmarket area, say organisers.<br />

The prestigious awards ceremony, hosted by the Newmarket<br />

Business Association (NBA) was held at the Langham hotel in Auckland<br />

on 22 June. NBA’s CEO, Mark Knoff-Thomas said the Newmarket<br />

business scene is thriving. “We always love these awards, as they<br />

bring together some of the best we have on offer in Newmarket. With<br />

just under 100 entries and 330 attendees who celebrated in typical<br />

Newmarket style on the night, this year was our biggest ever.”<br />

Holmes says just to get named as a finalist this year was an<br />

achievement, given his fellow finalists: Flo & Frankie, Scarpa Shoes<br />

and Superette. “It’s a pleasure being able to offer our customers a<br />

high level of service and exceptional products. Part of our success is<br />

due to our very close team who work together to achieve the best<br />

outcomes possible for each and every customer.”<br />

Michael Holmes Premium Eyewear is planning on opening a new<br />

practice in St Heliers later this year. ▀<br />

New MyDay ® toric:<br />

Where the Optimised Toric Lens Geometry TM of Biofinity ® toric<br />

meets the Smart Silicone TM chemistry of MyDay. ®<br />

Prescribe oxygen for your astigmatic patients today.<br />

Optimised Toric Lens<br />

Geometry TM<br />

© <strong>2017</strong> CooperVision.<br />

NEW<br />

TORIC<br />

UV<br />


Smart Silicone TM chemistry<br />

Optometry only in Australia and New Zealand<br />

*Features superpermeable Smart Silicone TM<br />

chemistry: the unique technology that has made<br />

MyDay ® the most prescribed 1-day lens. Data on file, 2016. CooperVision ANZ.<br />


<strong>Aug</strong>ust <strong>2017</strong><br />

NEW<br />

TORIC<br />

World-class 1-day<br />

silicone hydrogel toric lens<br />



Focus on<br />

Eye Research<br />

Krill vs fish oil and other<br />

eye treatments<br />






DISEASES. Miyazaki et al.<br />

Ophthalmology <strong>2017</strong>;124:287-94<br />

In this retrospective Japanese study,<br />

791 patients with severe allergic eye<br />

disease responding poorly to treatment<br />

with conventional anti-allergy<br />

medication (including topical steroid<br />

in 57%) were enrolled for treatment<br />

either with topical tacrolimus<br />

0.1% alone or in combination with<br />

fluorometholone or betamethasone.<br />

The mean age was 15 years with a<br />

preponderance of males (83%). Patients<br />

with corneal epitheliopathy related<br />

to allergy were included, ranging in<br />

severity from punctate epitheliopathy<br />

to shield ulcers (30%). Papillary<br />

conjunctivitis was also graded.<br />

All three groups had good<br />

improvement in corneal epitheliopathy<br />

score with no significant difference<br />

between the tacrolimus-alone group<br />

and the tacrolimus with steroid groups.<br />

There was no significant difference in<br />

the time course for improvement either<br />

and the beneficial effects applied to<br />

the most severe form of epitheliopathy,<br />

those with shield ulcers.<br />

Comment: This is a large number of<br />

cases of a relatively rare condition.<br />

The mainstay of therapy is generally<br />

topical steroids for those cases not<br />

adequately controlled with agents<br />

such as olopatadine. Chronic steroid<br />

treatment, of course, comes with risks<br />

including IOP elevation and cataract<br />

development. Use of topical tacrolimus<br />

alone seems safe and remarkably<br />

effective. Tacrolimus is a potent<br />

inhibitor of T-cells and is available<br />

in New Zealand in ointment form<br />

(Protopic 0.1%) or can be compounded<br />

by some pharmacies. It may sting<br />

transiently on instillation but<br />

otherwise seems well tolerated.<br />





EYE DISEASE. Deinema et al.<br />

Ophthalmology <strong>2017</strong>;124:43-52<br />

To assess the efficacy of two forms<br />

of oral omega-3 supplement, krill oil<br />

(phospholipid) was compared to fish<br />

oil (triacylglyceride) to placebo (olive<br />

oil) in three groups with 17 to 19<br />

participants in each group completing<br />

the 90-day study.<br />

Primary outcome measures were<br />

tear osmolarity and OSDI score with<br />

secondary measures including tear<br />

stability, ocular surface staining, tear<br />

production and volume, meibomian<br />

gland capping and tear cytokine levels.<br />

At day 90, both the krill and fish<br />

oil groups had similar significant<br />

tear osmolarity reduction (-18.6 +/-<br />

4.5mOsm/l and -19.8 +/-3.9mOsm/l<br />

respectively, p

Visual testing for concussion<br />

Visual testing may prove to be the most reliable,<br />

portable and easiest test to implement in<br />

schools and amateur sports for concussion,<br />

say researchers. This is the theory being tested<br />

by a new study team lead by Australian neuroophthalmologist<br />

Professor Clare Fraser and Dr Adrian<br />

Cohen, a senior lecturer at Sydney Medical School.<br />

With no single, accepted, diagnostic test for<br />

concussion, the Sydney University research team<br />

aim to find a more accurate system to diagnose<br />

mild traumatic brain injuries (mTBI) that can be<br />

used by non-medical professionals at all levels of<br />

sport to prevent long-lasting damage, especially<br />

to developing brains in children and adolescents.<br />

What’s hot in the world of<br />

macular disease research<br />

Optometry’s evolving<br />

role in AMD<br />

Optometry is at the frontline of detection<br />

and management of age-related<br />

macular degeneration (AMD).<br />

The current optometry role includes screening<br />

for early AMD; disease monitoring; lifestyle<br />

education, including modifiable risk factors;<br />

symptom awareness and vision self-monitoring;<br />

nutritional supplement treatment; and quality<br />

referral of wet AMD.<br />

We can expect this role to expand with a<br />

rapidly ageing population, an increasing burden<br />

of wet AMD treatment and the likelihood<br />

that there will be more validated treatments<br />

for intermediate AMD and late AMD with<br />

geographic atrophy.<br />

Screening<br />

Optometry currently screens for early AMD<br />

through non-targeted comprehensive eye<br />

examinations. The case for a governmentfunded<br />

AMD screening programme is being<br />

well made and is close. Screening for early<br />

AMD fulfils the World Health Organisation’s<br />

guidelines in the most part: it is an important<br />

health problem, has an accepted treatment and<br />

an early and asymptomatic stage. There remain<br />

two areas where modifications are required<br />

to make the screening case: improvements in<br />

detection and making the cost of detection<br />

economically balanced in relation to total<br />

medical expenditure.<br />

The problem with detection lies with the<br />

reliability of dilated fundus examination. A<br />

recent study in the States found 25% of AMD<br />

cases were missed by primary eye specialists<br />

(both optometrists and ophthalmologists).<br />

One third of these had intermediate AMD that<br />

would have been treatable with nutritional<br />

supplements had it been diagnosed. Potential<br />

means for improving this poor detection rate<br />

includes the increasingly widespread use of OCT<br />

imaging and some progress towards automated<br />

analysis of colour photo and OCT using big data<br />

algorithms.<br />

The economics of screening a very large, older<br />

population is problematic. There are currently<br />

around 1.2 million over 55-years-old in New<br />

Zealand. To reduce the enormity of the task,<br />

we can choose to screen only those at greater<br />

risk; the most obvious way to do this is by<br />

age. Increasing the threshold to 65 years old<br />

reduces the current screening population to<br />

700,000, but a rapidly ageing population means<br />

this age-group is projected to rise to a mindboggling<br />

1.4 million by 2046. Thus, other risk<br />

factors may be chosen to further reduce the<br />

screening population. A recent study from Italy,<br />

for example, validated a very simple 12-item<br />

STARS (Simplified Théa AMD Risk-assessment<br />

Scale) questionnaire for general practitioners,<br />

that results in an AMD-risk score for over<br />


The issue has been made more serious by the<br />

deaths of several junior players around the world<br />

from ‘second-impact syndrome’. The players died<br />

following a second blow to the head before they<br />

had fully recovered from a previous concussion,<br />

causing the brain to swell catastrophically.<br />

“Unfortunately, only professional sports teams have<br />

doctors on the sidelines,” said Prof Fraser.<br />

The University team has been working with the<br />

Sydney-based Ranwick Rugby Union Club for the<br />

past three years analysing how visual processing<br />

can be used to better diagnose concussion. They<br />

already have data from over 100 male rugby players<br />

(aged 18 to 35 years) and plan to have their first<br />


55-year-olds. This focuses on risk factors such<br />

as cardiovascular disease, socio-demographic<br />

characteristics, family history and systemic<br />

and ocular risk factors, resulting in three risk<br />

categories: low, moderate and high. The study<br />

found good discrimination of patients with and<br />

without AMD. However, such a tool would first<br />

need to be validated for our population.<br />

Patient education<br />

Optometry has the lead role in patient<br />

education. Once early AMD is detected, patients<br />

need to be aware of modifiable risk factors such<br />

as smoking and diet. To monitor for progression<br />

of early AMD, an annual optometric review<br />

is likely to be sufficient. Once intermediate<br />

AMD has developed, commencing AREDS-2<br />

nutritional supplements is the standard of<br />

care. It is crucial the patient is knowledgeable<br />

about the early symptoms of wet AMD and<br />

performing regular Amsler grid testing.<br />

Quality referral of suspected wet AMD has<br />

a direct impact on the likelihood of timely<br />

treatment and visual outcome. Fortunately,<br />

optometry’s rapid adoption of OCT imaging<br />

should be improving detection and quality<br />

referral.<br />

Wet AMD management<br />

It is likely that the role of optometry in the<br />

management of wet AMD will expand. A direct<br />

driver will be that ophthalmology is struggling<br />

with the need to manage regular anti-VEGF<br />

therapy and is seeking alternative models<br />

of care. This has led to the adoption of new<br />

strategies such as nurse-led clinics. Where may<br />

optometry fit into this? Optometry is now very<br />

capable of disease monitoring after completion<br />

of anti-VEGF therapy but this resource is underutilised.<br />

Participation in wet AMD treatment, in<br />

a similar model as nurse-led clinics, is feasible<br />

but will require specific supervised training.<br />

So busy times are ahead for both optometry<br />

and ophthalmology to improve our<br />

management of the AMD epidemic. ▀<br />

See separate story about the government’s Tier<br />

3 report on AMD on p7.<br />

About the author<br />

*Dr David Worsley is a<br />

medical and surgical retinal<br />

specialist at Hamilton Eye<br />

Clinic and Waikato Hospital<br />

with a particular interest<br />

in the rapidly evolving<br />

treatments for AMD. He<br />

is a trustee for Macular<br />

Degeneration New Zealand.<br />

study submitted for publication<br />

this month. Further tests will<br />

continue throughout the <strong>2017</strong><br />

rugby season to measure<br />

changes to the brains visual<br />

stimulus processing.<br />

“The main issue with mTBI<br />

is the broad definition and<br />

the lack of strong diagnostic<br />

criteria. Players with<br />

concussion may risk serious<br />

health effects if they return<br />

to the sport too soon,” said<br />

Prof Fraser. “We hope these<br />

tests can be used by nonmedical<br />

professionals to guide them on when to<br />

remove a player from the field and send them for<br />

assessment and possible treatment.”<br />

The visual system accounts for over 50% of the<br />

brain circuitry and the visual pathways are in areas<br />

particularly vulnerable to shear-injuries in a head<br />

blow, she said. “We are assessing saccadic eye<br />

movements as well as visual evoked potentials, to<br />

determine which tests can be used in diagnosis of<br />

concussion.”<br />

Dr Philip Boughton at the University of Sydney’s<br />

Faculty of Engineering & Information is working<br />

with the team to develop a suite of technologies,<br />

including wearable biosensors, to better detect<br />

and assess traumatic brain injuries. “We’re trying<br />

to build technology that can track and relay realtime<br />

data on the acceleration, deceleration and<br />

rotation of players’ heads and necks. We want<br />

these biosensors to indicate not only concussive<br />

single impacts but also tell us when several smaller<br />

impacts could add up to a concussion,” he said in<br />

a Sydney University news article. “At the moment,<br />

we are in the prototype stage, however the plan<br />

is to implant this technology into a mouthguard.<br />

The hope is when a force that is likely to result<br />

in a concussion or brain injury is detected, the<br />

mouthguard will change colour or vibrate, alerting<br />

the player, training staff and referee to the injury.”<br />

Dr Cohen is calling the new device a<br />

‘concussionometer’. “(Currently) it’s a portable<br />

headset using clinically validated, patented<br />

technology to measure the brain’s electrical activity.<br />

The test takes two minutes to tell us when a player<br />

is concussed and has to leave the field and when<br />



A new, long-term study aims to improve concussion diagnosis in schools and amateur sports<br />

TECNIS ®<br />


they are safe to return to playing, the results are<br />

recorded on a smartphone and stored online.”<br />

New Zealand’s involvement<br />

After three years working as the chief medical officer<br />

with the Westpac Rescue Helicopter Service, when<br />

he treated hundreds of trauma and medical cases,<br />

Dr Cohen founded Necksafe, and its concussion<br />

programme Headsafe, dedicated to the elimination<br />

of preventable head and neck injuries through<br />

advocacy, awareness, education, and research.<br />

Headsafe is not only involved in the Sydney<br />

University study, but also with a global rugby player<br />

health research project together with researchers<br />

and sports organisations in New Zealand.<br />

This international, ground-breaking research is<br />

looking at the long-term effects of concussion on<br />

retired rugby players pulling together studies from<br />

Auckland University of Technology (AUT), the UK,<br />

Canada and Australia. The Kiwi study, led by AUT<br />

Professor Patria Hume, found rugby players who’d<br />

experienced one or more concussions had some<br />

cognitive limitations compared with those players<br />

with no history of concussion.<br />

Concussion is a common traumatic brain injury<br />

that can have lifelong effects. Globally there are 10<br />

million concussions every year and five million of<br />

these are children and adolescents. According to<br />

the Accident Compensation Corporation (ACC) $75<br />

million was spent on concussion in New Zealand in<br />

the last three years.<br />

“The long-term effects of participation in sport<br />

need to be understood and acknowledged in order<br />

for us to care for players today and in the future,”<br />

said Dr Cohen. ▀<br />

TECNIS is a trademark owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates. All other trademarks are the intellectual property of their respective owners.<br />

AMO Australia Pty. Limited. Level 3, 299 Lane Cove Road, Macquarie Park, NSW 2113. AMO Australia Pty. Limited (Incorporated in Australia) PO Box 401, Shortland Street, Auckland, 1140.<br />

© <strong>2017</strong> Abbott Medical Optics Inc. | www.vision.abbott | PP<strong>2017</strong>CT0286<br />

AMO20530 Tecnis PCIOLs Adv_JJ_A4_FP.indd 1<br />

<strong>Aug</strong>ust <strong>2017</strong><br />


21<br />

31/3/17 5:12 pm

for optometrists and eye care professionals<br />

with<br />

Prof Charles McGhee<br />

& A/Prof Dipika Patel<br />

Series Editors<br />

Botulinum toxin in oculoplastics<br />

Botulinum neurotoxin type A (BTX-A) molecule<br />

Once touted as the most toxic poison known,<br />

Clostridium botulinum neurotoxin (BoNT)<br />

has revolutionised the treatment of a<br />

broad array of periocular diseases. Its efficacy and<br />

low risk mean it is now one of the most frequently<br />

used medications in ophthalmic plastic surgery 1 .<br />

First recognised as a safe and efficacious<br />

therapeutic agent by Allan Scott in the 1970s for<br />

treatment of strabismus via extraocular muscle<br />

injection, the use of BoNT has since evolved to<br />

become standard therapy for movement disorders<br />

such as blepharospasm and other facial dystonias to<br />

many neurologic and non-neurologic disorders 1-3 .<br />

BoNT type A is the strongest of seven serotypes<br />

identified. It paralyses muscle by inhibiting the<br />

release of acetylcholine (Ach) from vesicles at the<br />

presynaptic nerve terminal of the neuromuscular<br />

junction, decreasing contraction of the motor<br />

unit. There is some evidence suggesting BoNT may<br />

also modify sensory and proprioceptive input via<br />

an effect on central motor neurones. Continued<br />

release of Ach for several days means the onset of<br />

effect may be two to four days. From a therapeutic<br />

point of view, treatment generally remains<br />

effective for three to four months after injection<br />

and restoration of muscle activity is thought to<br />

be secondary to regeneration of new motor end<br />

plates, reduced levels of acetylcholinesterae and<br />

extra-junctional acetylcholine receptors 1,4 .<br />

There are currently four neurotoxin formulations<br />

available for injection, OnabotulinumtoxinA<br />

(Botox, Allergan), AbobotulinumtoxinA (Dysport,<br />

Ipsen), IncobotulinumtoxinA (Xeomin, Merz) and<br />

RimabotulinumtoxinB (Myobloc, Solstice) 3,5 .<br />



Professional<br />

Enrol in our online Professional Education Programme,<br />

approved by the ODOB CPD Accreditation Committee<br />

for a maximum of 10.5 Clinical Diagnostic (CD) Credits.<br />

Seven new cases each year.<br />

Register for our Glaucoma Symposium to be held on<br />

Sunday 13 <strong>Aug</strong>ust. This is a one day education event<br />

for optometrists and other eye health professionals. The<br />

overall theme of the Symposium is ‘Glaucoma – from<br />

Diagnosis to Management. The scientific programme<br />

is being overseen by Professor Helen Danesh-Meyer.<br />

Speakers from both ophthalmology and optometry will<br />

be present.<br />

Community<br />

Become a member of Glaucoma NZ and have access<br />

to a wide range educational resources to have in your<br />

practice. Be kept up to date with what’s happening with<br />

glaucoma in our Eyelights newsletter.<br />

Be part of GNZ’s official Speakers’ Database. Are you<br />

interested in talking to the community about glaucoma<br />

and eye health on behalf of GNZ, and are happy to be<br />

approached to speak to groups in your area, please<br />

contact us.<br />

Visit www.glaucoma.org.nz, phone 0800 452 826,<br />

email info@glaucoma.org.nz<br />

Although BoNT is<br />

a foreign protein,<br />

secondary nonresponse<br />

with<br />

production of<br />

antibodies against<br />

botulinum toxin<br />

A is extremely<br />

rare. There is very<br />

little evidence of<br />

tachyphylaxis.<br />

BoNT “units” are<br />

defined by mouse<br />

toxicity trials and<br />

while comparative<br />

efficacy is fairly<br />

similar in regards to<br />

potency, speed of<br />

onset, therapeutic<br />

duration and<br />

immunogenicity,<br />

there is no true<br />

“equivalent” dosing<br />

paradigm between<br />

different BoNT<br />

preparations.<br />

The lethal dose<br />

of Botox is estimated to be 2500-3000 units for a<br />

70kg person. Typical periocular treatments are in<br />

the order of 20-50 units 1 .<br />

Facial dystonias<br />

Benign essential blepharospasm and hemifacial<br />

spasm are two of the most common disorders<br />

affecting the face. These facial dystonias can<br />

render patients functionally blind and adversely<br />

affect quality of life; causing depression, anxiety,<br />

ocular pain and difficulties with driving.<br />

Benign essential blepharospasm (BEB) is a<br />

bilateral pattern of focal dystonia involving the<br />

muscles surrounding the eyes that manifests<br />

clinically as sustained spasms of the eyelid<br />

protractors resulting in excessive blinking,<br />

photophobia and persistent eye closure in<br />

the absence of any adnexal cause. BEB affects<br />

32/100,000 people, typically in the fifth to<br />

sixth decade of life; affecting women more<br />

frequently than men in a 3:1 ratio. The aetiology is<br />

unknown 4,6 .<br />

A subset of blepharospasm patients display<br />

forceful contraction of jaw and tongue, as well<br />

as chin thrusting, consistent with oromandibular<br />

dystonia, a combination commonly described as<br />

cranial dystonia or “Meige syndrome”.<br />

A patient with hemifacial spasm<br />

Hemifacial spasm (HFS) is characterised by<br />

unilateral intermittent sustained contractions of<br />

the muscles of facial expression supplied by the<br />

facial nerve. Hemifacial spasm commonly is of<br />

insidious or subacute onset, peaking in middle age,<br />

although it can occur anywhere from the third to<br />

seventh decade of life but is less common than<br />

BEB. Women are affected more frequently than<br />

men, 2:1. It is usually chronic and progressive and<br />

may cause patients significant social disability.<br />

The most commonly identified aetiology is<br />

vascular compression of the intracranial portion of<br />

the facial nerve. Neurosurgical treatment options<br />

are available but patients may elect for a less<br />

invasive treatment modality.<br />

High-level evidence exists for the treatment of<br />

facial dystonias with BoNT and clinical response<br />

rates are reported to be greater than 90% and to<br />

clinically correlate with improved quality of life.<br />

Studies show persisting efficacy over a 15-year<br />

period in patients treated for BEB, HFS<br />

and Meige syndrome, with very low<br />

incidence of adverse effects. The average<br />

duration of effect and dose required<br />

for treatment remains unchanged<br />

in short and long duration follow-up<br />

studies, once an effective dose has been<br />

established by titration.<br />

Subcutaneous injections into<br />

orbicularis oculi of upper and lower lids<br />

and the corrugator supracilii muscles of<br />

the eyebrows are performed. Patients<br />

with blepharospasm are typically<br />

injected every three to four months<br />

while those with hemifacial spasm every<br />

four to six months.<br />

Efficacy can be evaluated two to four weeks after<br />

initial injection and the sites and doses titrated to<br />

response for subsequent injections 1,6 .<br />

Cosmesis<br />

The past 15 years have seen an explosion in<br />

the use of BoNT for the treatment of facial<br />

wrinkles or rhytids. The superficial facial mimetic<br />

muscles insert directly into the under surface<br />

of the skin; repetitive contraction therefore<br />

causes characteristic furrows perpendicular<br />

to the direction of contraction. These so called<br />

“dynamic” rhytids contrast with “static” rhytids,<br />

caused by thinning of the dermis. Dynamic rhytids<br />

commonly occur in the upper third of the face<br />

(brow and periorbital regions) and are amenable<br />

to management with chemodenervation agents. It<br />

is important to recognise that chemodenervation<br />

will not treat static rhytids, which may require<br />

other facial rejuvenation techniques such as peels,<br />

laser resurfacing and fillers.<br />

Glabellar furrows are primarily caused by<br />

contraction of the corrugator supracilii, procerus<br />

muscles and medial orbicularis muscles, and<br />

respond very well to BoNT injections. Effects may<br />

last up to six months. A “chemical brow lift” may<br />

be achieved by combining with injection of the<br />

lateral orbicularis, which is a lateral depressor of<br />

the brow.<br />

Horizontal forehead wrinkles arise from<br />

contraction of the twin belly frontalis muscle. BoNT<br />

injections are placed evenly 2-3cm above the orbital<br />

rim with care not to cause a brow ptosis especially<br />

in patients with blepharoptosis and Asians with<br />

particularly heavy lids 5 .<br />

Aberrancy<br />

Involuntary co-contraction of the orbicularis oculi<br />

and the orbicularis oris muscle when the patient<br />

speaks, smiles, laughs or opens the jaw, secondary<br />

to ocular facial synkinesia, results in pseudo-ptosis,<br />

otherwise known as Marin Amat syndrome. This<br />

synkinesia is secondary to aberrant regeneration of<br />

the facial nerve after palsy of various aetiologies,<br />

including trauma, Bells palsy, Ramsay Hunt<br />

syndrome, polyneuritis and surgery.<br />

The frequency of such aberrant regeneration<br />

phenomena is not well documented, but mild forms<br />

are probably quite common. The abnormal facial<br />

movements are often undesirable to the patient,<br />

causing visual obstruction, and are cosmetically<br />

displeasing, causing unintended social cues.<br />

The use of BoNT to correct the symptomatic<br />

blepharospasm component of the synkinesis,<br />

as well as biofeedback is now the mainstay of<br />

treatment 4 .<br />

Lacrimation<br />

Watering results from either lacrimal obstruction<br />

(epiphora) or hypersecretion of tears from the<br />

lacrimal gland (lacrimation). Hypersecretion may<br />

be reflex in nature, secondary to adnexal disease<br />

or due to aberrant regeneration of the facial nerve,<br />

particularly while chewing or talking (crocodile<br />

tears).<br />

Invasive treatment options include<br />

dacryocystorhinostomy, with or without Lester-<br />

Jones tube placement, partial lacrimal gland<br />

excision, sphenopalatine block and radiotherapy,<br />

but Botox injected into the palpebral lobe of the<br />

lacrimal gland can also be very effective. Studies<br />

have shown nearly 75% of patients have subjective<br />

elimination of epiphora,17% improved but still<br />

had tearing, and 9% little or no effect. A temporary<br />

induced ptosis was the commonest side effect,<br />

occurring in approximately 11%.<br />

This procedure can easily be performed in a<br />

BoNT has revolutionised treatment of periocular facial movement disorders<br />

clinical setting with few transient adverse effects<br />

and a high-patient satisfaction7.<br />

Adverse effects<br />

Primary non-response is uncommon and<br />

may be due to misdiagnosis, adnexal disease<br />

causing sensory blepharospasm, inadequate or<br />

inappropriate treatment and handling errors.<br />

Thankfully, contraindications to BoNT injection<br />

are rare, but should be avoided in pregnancy<br />

and lactation. Neuromuscular disorders such as<br />

myasthenia gravis, Eaton-Lambert syndrome and<br />

amyotropic lateral sclerosis can theoretically be<br />

worsened by neurotoxin injections 5 .<br />

The clinical safety of BoNT injections has been<br />

well established in large series studies and<br />

thankfully most adverse events are minor and<br />

self-limiting, occurring in around 5-10% of cases.<br />

The titration period carries a risk of both under and<br />

overtreatment, but this reduces as the effective<br />

treatment regimen is identified.<br />

Bruising, swelling and haematoma formation are<br />

the most common adverse events. Injections into<br />

periocular area can cause blepharoptosis, diplopia,<br />

lower-lid malpositions including entropion and<br />

ectropion. Excessive weakening of orbicularis can<br />

lead to lagophthalmos and corneal epitheliopathy,<br />

making artificial lubricants essential in the early<br />

post-injection period. An early review after initial<br />

treatments is usually prudent. The injection<br />

technique is extremely important in minimising<br />

side effects and maximising therapeutic effect.<br />

Summary<br />

BoNT has revolutionised treatment of periocular<br />

facial movement disorders, virtually eliminating<br />

the extensive surgery that used to be patients’<br />

only treatment option. The increasing use of BoNT<br />

for cosmesis carries risks of corneal exposure and<br />

it should be considered as a possible cause in<br />

all patients seen with ocular surface symptoms.<br />

Fortunately, such side effects are almost always<br />

transient, mild and respond well to conservative<br />

management. ▀<br />

References<br />

1. Harrison AR. Chemodenervation in facial<br />

dystonias and wrinkles. 2003. Current Opinion in<br />

Ophthalmology;14(5):241-245<br />

2. Hallet M, Albanese A, Dressler D, Segal KR, Simpson D,<br />

Truong D, Jankovic J. Toxicon 2013:67:94-114<br />

3. Erikson BP, Lee WW, Cohen J, Grunebaum LD. The role of<br />

neurotoxins in the periorbital and midface ares. Facial<br />

Plast Surg Clin N Am 2015; 243-255<br />

4. McElhinny ER, Reich I, Burt B, Mancini R, Wladis<br />

E, Durairaj VD, Shinder. Treatment of pseudoptosis<br />

secondary to aberrant regeneration of the facial nerve<br />

with botulinum toxin type A. Ophthal Plast Reconstr Surg<br />

2013;29 (3):175-178<br />

5. Chundury RV, Couch SM, Holds JB. Comparison of<br />

preferences between OnabotulinumtoxinA (Botox) and<br />

IncobotulinumtoxinA (Xeomin) in the treatment of benign<br />

essential blepharospasm. (2013) Ophthal Plast Reconstr<br />

Surg 29(3): 205-7<br />

6. Czyz CN, Burns JA, Petrie TP, Watkins KV, Foster JA. 2013.<br />

American Journal of Ophthalmology 156:173-177<br />

7. Wojno TH. Results of lacrimal gland botulinum toxin<br />

injection for epiphora in lacrimal obstruction and<br />

gustatory tearing. Ophthal PLast Reconstr Surg 2011;<br />

27:119-121<br />

Dr James Slattery<br />

About the author<br />

* Dr James Slattery MBBS,<br />

PhD, B Sci (Biomed) is an<br />

oculoplastics fellow at the<br />

University of Auckland. He<br />

completed his ophthalmology<br />

training in Adelaide, South<br />

Australia.<br />

22 NEW ZEALAND OPTICS <strong>Aug</strong>ust <strong>2017</strong>

Eye Doctors at Ormiston<br />

The annual Eye Doctors<br />

Grand Round at Ormiston<br />

Hospital on Wednesday<br />

28 June was kicked-off by<br />

Dr Andrew Riley discussing<br />

anaesthesia. The invited<br />

audience, of around 30 South<br />

Auckland-based optometrists,<br />

listened intently as Dr Riley<br />

discussed the different<br />

types of anaesthesia they<br />

might encounter and the<br />

pharmacology of how they<br />

work.<br />

Anaesthetics and<br />

medication<br />

Topical and local anaesthetic<br />

cause depolarisation along<br />

the nerve cell membranes<br />

blocking signals. Physiologic<br />

activity of local anaesthetics is a function of their<br />

lipid solubility, diffusibility, affinity for protein<br />

binding, percent ionization at physiologic pH and<br />

vasodilating properties.<br />

For tonometry, the use of oxybuprocaine is<br />

common. Oxybupivicaine, however, is not very<br />

potent but causes less stinging. For cataract<br />

surgery, intravitreal injection or corneal foreign<br />

body removal, a more potent anaesthetic like<br />

tetracaine might be used. This anaesthesia lasts<br />

longer than oxybuprocaine, but does sting on<br />

application, so oxybuprocaine might be used first<br />

to take the edge off. Lid surgery requires injected<br />

anaesthesia, for example, lignocaine with adrenaline.<br />

Adrenaline helps by causing vasoconstriction. Newer<br />

anaesthetics like ropivicaine and bupivacaine are<br />

now widely used as they are less toxic and last longer.<br />

Patients must have an empty stomach (nil-bymouth<br />

six hours prior) for general anaesthetic to<br />

reduce the chance of aspiration which can be life<br />

threatening. If you see someone with a penetrating<br />

eye injury tell them not to eat as it will delay surgery,<br />

said Dr Riley.<br />

Most medications are fine to be continued for<br />

cataract surgery, however with other types of eye<br />

surgery some medications will be stopped. Thus, the<br />

risk of stopping an anticoagulant, for example, must<br />

be balanced against surgical risk.<br />

Infantile capillary haemangioma<br />

Dr Shuan Dai took the floor next to discuss<br />

periocular infantile capillary haemangioma, which<br />

is one of most common benign tumours around<br />

eyelids for kids. They are more common in female,<br />

premature, Caucasian infants and often start as a<br />

small nodule at birth, gradually expanding in the<br />

first couple of years.<br />

Traditionally, visually-significant haemangiomas<br />

have been treated with intralesional steroid<br />

injections. Other common treatments include<br />

surgical excision, if the haemangioma is localised<br />

and well-defined, or the use of interferon alfa-2a.<br />

They can also be treated with pulsed laser, but this<br />

can leave faint scars or depigmentations, said Dr Dai<br />

adding that systemic beta-blockers have also been<br />

found to be an effective, relatively new treatment<br />

for children with significant haemagioma.<br />

Another treatment Dr Dai said he has had much<br />

success with is Timoptol XE gel (timolol maleate<br />

0.5%). This works well for superficial haemangiomas,<br />

if treated early, with no obvious side effects, he said.<br />

Ocular complications of psychotropics<br />

After a short break, Dr Penny McAllum discussed<br />

ocular complications of psychotropic medications,<br />

noting that up to 20% of New Zealanders are<br />

diagnosed with significant psychiatric disorders at<br />

some stage in their lives. She decided to look into<br />

this topic after a patient complained she couldn’t<br />

leave a dark room without a pillow over her face,<br />

thus raising the question is this a complication of<br />

her patient’s psychotropic medication, a real ocular<br />

condition or a result of her patients’ mental health<br />

disorder? She said.<br />

When she was at medical school phenothiazines<br />

were popularly prescribed, said Dr McAllum, but<br />

are not popular any longer due to harsh side<br />

effects. These days preferred psychotropics include<br />

aripiprazole and risperidone, whose main problems<br />

stem from long-term use, including cataracts,<br />

with asymmetric flower like patterns. Pigmentary<br />

retinopathy can be caused after 20 to 30 years of<br />

use on phenothiazines. It is irreversible and can<br />

be picked up early from symptoms such as nightblindness<br />

and peripheral vision issues.<br />

Selective seratonin reuptake inhibitors (SSRIs),<br />

such as Prozac, are common drugs prescribed today<br />

for anxiety disorders, with around 400,000 Kiwis<br />

said to be on antidepressants at any one time. They<br />

can be associated with oculogyric crisis and may<br />

increase aqueous production, so patients need<br />

Drs Shuan Dai, Mark Donaldson, Andrew Riley and Penny McAllum<br />

regular pressure checks, she said.<br />

Mood stabilisers like lithium can cause dry eyes<br />

and increased tear osmolality. Fortunately, this<br />

often rights itself after a few weeks with, rarely,<br />

eye movement disorders, acute optic swelling<br />

and reversible vision loss seen as additional side<br />

effects. Dr McAllum also noted that stimulants<br />

such as Ritalin and dexamphetamine, prescribed to<br />

children with ADHD, can cause blurred vision, while<br />

anticonvulsants like Topamax, which is also used to<br />

treat migraines, can cause sudden refractive change<br />

due to swelling of the ciliary body.<br />

Returning to the patient who initiated this<br />

interest, she noted she had been on antipsychotics<br />

for a long time and was also on lithium, so her<br />

increased-light sensitivity was probably related to<br />

this. Fortunately, she improved to a manageable<br />

level with time and supportive treatments, such<br />

as artificial tear supplements, said Dr McAllum. A<br />

patient may not always tell you they’re on these<br />

drugs, so it always pays to ask, she said.<br />

Diagnosing and dealing with ACG<br />

Dr Mark Donaldson shared an interesting case study<br />

of a 49-year-old woman who went to her general<br />

practitioner twice in one week complaining of<br />

headaches. The second time she was admitted to<br />

the acute medical service of public hospital, but it<br />

was a further two weeks before she was correctly<br />

diagnosed with angle-closure glaucoma (ACG).<br />

ACG can present with a crisis of pressure, but it’s<br />

more commonly sub-clinical, he said, while lens<br />

removal, long-known to be a definitive treatment for<br />

angle closure, has now been confirmed in a threeyear,<br />

international randomised, controlled clinical<br />

study, called the EAGLE trial.<br />

Selective laser trabeculoplasty is effective for all<br />

glaucoma sub-types, with minor adjustments to<br />

the treatment often offering specific patients more<br />

favourable outcomes, he added.<br />

Dr Donaldson also introduced the audience<br />

to a relatively new ciliary body laser procedure,<br />

micropulse transscleral cyclophotocoagulation. The<br />

side effect profile of this treatment is relatively safe<br />

in comparison to standard cyclophotocoagulation<br />

and can lead to a significant decline in the number<br />

of post-operative medications needed, he said.<br />

New practice manager for Eye Drs<br />

Former Eye<br />

Doctors’<br />

practice<br />

manager<br />

Lorraine Beattie<br />

has left the<br />

practice to<br />

pursue her<br />

dream of<br />

becoming a<br />

professional<br />

photographer.<br />

Talking at<br />

their recent<br />

seminar<br />

Julie Kellow and Lorraine Beattie<br />

evening in<br />

Ormiston, the Eye Doctors’ team, Drs Andrew Riley,<br />

Shuan Dai, Penny McAllum and Mark Donaldson,<br />

thanked her for all her hard work, said she will be<br />

missed, and introduced new practice manager<br />

Julie Kellow.<br />

Kellow told NZ Optics though she was new to<br />

ophthalmology, she had been working for two<br />

plastic surgeons in a “busy practice” in Remuera<br />

for a number of years. Prior to this she spent<br />

10 years in the finance industry as an office<br />

administrator. “I’m enjoying working with Eye<br />

Doctors and leaning about all things optic!” she<br />

said.<br />

To see examples of Lorraine Beattie’s work visit,<br />

www.lorrainebeattie.com<br />

Eye opening travel<br />

Shore Temple in Southern India<br />

Combining pleasure and education, Jon<br />

Baines Tours runs specialist study tours<br />

looking at the culture and society of a<br />

country through the prism of a professional focus,<br />

be it medical, teaching or engineering. Each year<br />

the company runs two, CPD-eligible tours aimed<br />

directly at the eye health community, one for<br />

ophthalmologists and one for optometrists.<br />

Kiwi optometrist John Kelsey, went on one of<br />

the company’s study tours to South India in 2011,<br />

and says the tours give you access to places you<br />

wouldn’t normally be given, tailored to eye health<br />

practitioners’ passion for what they do. “I hike a lot<br />

in Nepal and other places and while you see many<br />

things as a tourist, there are places you don’t have<br />

access to. You don’t get a chance to go and look in<br />

eye hospitals or meet the doctors and staff, or see<br />

how rural screening programmes are run.”<br />

The good thing about study tours is they are<br />

both educational and recreational, he says, so you<br />

see a lot of cultural sights and get to learn how<br />

eyecare operates in a country quite different to<br />

Ophthalmology in North India<br />

18 February – 2 March 2018<br />

Tour leader: Professor Harminder Dua<br />

www.jonbainestours.co.uk/ophthal<br />

Optometry and Eyecare in Nepal<br />

8 – 19 April 2018<br />

Tour leader David Shannon<br />

www.jonbainestours.co.uk/optometry<br />

Jon Baines Tours study tours are fully escorted and combine<br />

a rich cultural itinerary with a range of professional visits.<br />

For a brochure please contact us on:<br />

Tel: +61 (0)3 9343 6367<br />

Email: info@jonbainestours.com.au<br />

www.jonbainestours.com<br />

New Zealand. “It’s remarkable to see how these<br />

countries deliver eyecare where there is limited<br />

government funding and people are very poor.”<br />

Looking at educational facilities and eye<br />

hospitals in a country like India, highlighted<br />

both the similarities and the differences in<br />

approaches, such as seeing how traditional<br />

Ayurvedic medicines are used to treat glaucoma<br />

and other eye diseases, says Kelsey. “It was very<br />

interesting to see how alternative treatments<br />

are used alongside more conventional drug and<br />

surgical treatments… It’s an eye opener on so<br />

many levels.”<br />

Next year, Jon Baines Tours is running two<br />

specialist eyecare tours: ophthalmology in North<br />

India, led by Professor Harminder Dua, chair of<br />

ophthalmology at Nottingham University in<br />

the UK, from 18 February to 2 March 2018; and<br />

optometry and eyecare in Nepal, led by UK-based,<br />

European development manager for Optometry<br />

Giving Sight, Dr David Shannon, from 8-19 April<br />

2018. For more, see ad this page. ▀<br />

<strong>Aug</strong>ust <strong>2017</strong><br />



Style-Eyes<br />

Baby, what have you done?<br />

If you can, cast your mind back to 2004.<br />

It was a pretty big year. The largest<br />

passenger ship ever built, the RMS Queen<br />

Mary 2 made its maiden voyage, Janet<br />

Jackson suffered a wardrobe malfunction,<br />

The Lord of the Rings: Return of the King<br />

won 11 academy awards, Google introduced<br />

Gmail, Shrek the Kiwi sheep was finally<br />

shorn after six years’ avoidance, TV sitcom<br />

Friends aired its final show and Martha<br />

Stewart went to prison.<br />

For me, it was a pretty big year too. We<br />

had just become homeowners, we had just<br />

become first-time parents, I had just gone<br />

back to work full-time and been promoted.<br />

Things were hectic. I was stressed, sleep<br />

deprived and everything seemed a bit blurry.<br />

Getting back to work for me, also meant<br />

being dragged kicking and screaming back<br />

into the adult world. I used my child-free<br />

lunch breaks for banking cheques (they were<br />

still a thing back then), dental checkups,<br />

haircuts, and yes, an eye checkup. That’s<br />

when things became a little clearer.<br />

My distance vision had become pretty<br />

shocking and my lovely optometrist, David,<br />

was initially a little perplexed at how that<br />

could have occurred so quickly since my last<br />

visit. I explained I’d really noticed it at the<br />

end of a long day, after doing a lot of close,<br />

computer work since having such a long<br />

a break from work. “Why did you have a<br />

break from work?” he enquired. “I had time<br />

off since I had my baby!” It was a light bulb<br />

moment for David. “Well that explains it.<br />

Pregnancy will do it,” he said.<br />

Do what? I’d read the books, I’d seen the<br />

changes to my body – I was not fitting back<br />

into those size 8 Levis any time soon and a<br />

push-up bra was now on my Christmas wish<br />

list, and yes, I was aware pregnancy could<br />

affect my teeth but, honestly, I had no idea<br />

what pregnancy had to do with my eyes!<br />

If I focused on something up-close, such as<br />

a book or computer, when I looked up it took<br />

time for my eyes to refocus and, eventually,<br />

they didn’t refocus at all. I had never heard<br />

of it. I must have skipped that chapter in all<br />

those ‘What to expect’ new parent books.<br />

The women at work thought it was an old<br />

wives’ tale, and if it did happen, your eyes<br />

went back to normal after the birth. For<br />

some women they do, but not for me. So<br />

now I wear glasses. Now I know more:<br />

Connie’s top picks for smaller faces:<br />

Retro 339: Stepping back in time with the Retro<br />

339 by Dunelm. Lightweight frame and comfy<br />

arms to allow you to get on with your day.<br />


‘Water or fluid retention, a common side<br />

effect of pregnancy, may affect the thickness<br />

and shape of your cornea causing a vision<br />

change… that may result in blurry vision.”<br />

What, kid’s glasses too?<br />

Onto the next issue... choosing some<br />

glasses. This bit made me more emotional<br />

than learning about the myopia. I have a<br />

small face as it turns out, very small, as in I<br />

needed to select from the children’s section,<br />

how embarrassing. I was a fully-fledged<br />

adult now with the job, the mortgage and<br />

the offspring to prove it, but there I was<br />

trying to choose from glasses designed for<br />

children, and I’m not a purple or pink kinda<br />

girl. But bless Cheryl, the most amazing<br />

optometrist’s assistant that ever worked the<br />

floor. She was fantastic, quickly sweeping up<br />

options from the kid’s section and floating<br />

over to the ‘big person’ section for me to<br />

try them on and still feel like an adult. I still<br />

have that first set of frames she helped me<br />

choose as spares since I still love them – the<br />

way they sit, how lightweight they are, even<br />

the blue/green colour.<br />

While my eyesight has not degenerated<br />

any further, I’m still sporting specs and<br />

thanking the now-teen for all the results<br />

of her birth over the intervening years –<br />

someone please pass the hair dye and the<br />

wrinkle cream!<br />

*Connie Baker is a content and social media manager<br />

working with clients in Australia and New Zealand, and a<br />

proud specs wearer. “Glasses gave me back the confidence<br />

to get out and about without living life in a blur”.<br />

PZ Optics: Make a splash with a bit of colour<br />

in PZ Optics 1269 frames – perfectly suitable<br />

to smaller, more petite faces, teens and<br />

children.<br />

Fashion update<br />

Summer collections launched this month make us long for those bright, sunny summer<br />

days. Round shapes, metal and gold appear to be common themes. Here’s a selection of<br />

our favourite picks from this month’s news.<br />

Miu Miu<br />

The new Miu Miu summer collection is a “creative blend of vintage<br />

notes with modern detailing”, says the company. Model VMU 02Q<br />

featured here, is one of four new optical frames with a butterflyshaped<br />

front in two acetate layers, coloured in solid and transparent<br />

hues. The thin metal temples, with the Miu Miu lettering logo<br />

engraved, have colourful acetate tips. Available in combinations of pale<br />

pink and tortoise and black or navy and tortoise. Distributed by Luxottica.<br />

Xavier García<br />

Xavier García has also introduced a summer collection adding four more thin metal<br />

frames to its range. Some models are available in metallised colours (golds, rosé<br />

and gunmetal) paired with gloss or matte effects or in mono-colour<br />

solids with a matte finish. Coco, featured here, is a retro-rounded<br />

frame constructed from a block of worked steel combined<br />

with a colour pigment on its outer layer. The aviator styled<br />

Leal is a unisex frame, which has a reduced thickness on<br />

the internal face of the bridge, giving it flexibility, said the<br />

company. Distributed by Cardinal Eyewear.<br />

Ray-Ban<br />

Ray-Ban is mixing up new designs with re-mastered<br />

classics, like ‘The General’, this season. Included<br />

here is the new model, Ja-Jo; its extra-large round<br />

shape signalling true ‘60s spirit. Ja-Jo is available as<br />

Ogi Kids<br />

Ogi Kids has released youth-sized versions of two of Ogi’s most popular<br />

adult optical frames, using quality materials engineered to handle<br />

children’s active lifestyles. The newest additions to Ogi’s Mommy & Me,<br />

Daddy & I collection, the OK329 pictured here, is modelled after the<br />

bestselling 9223 from the Ogi Evolution series. The OK329 is handcrafted<br />

using two-tone acetate, combining colour with classic tortoiseshell.<br />

The soft-square silhouette suits many different face shapes, says the<br />

company, and the Flex Uno spring hinges, steel-core temples and<br />

adjustable tips enable precision fitting for a snug fit that stays put,<br />

whether at school or at play. Distributed by BTP International Designz.<br />

If you’re listed in the OIG and any of your brands are launching new<br />

ranges or have any fashion news, make sure NZ Optics is included on<br />

all their (and your) mailing lists so we can include any news in future<br />

‘Fashion Updates’. Email susanne@nzoptics.co.nz with all the details<br />

or to know more.<br />

C-Zone’s clever hinge tech<br />

Dutch brand C-Zone has introduced a new, “cool”, screw-less,<br />

spring-hinge system. The result of years of research, the<br />

completely new technology gives wearers a superior fit, says Rob<br />

Maas, director of C-Zone.<br />

C-Zone frames, which are all made from incredibly light-weight,<br />

German surgical steel, appeal particularly to men and this new hinge<br />

technology adds to that as it’s very technical, attractive, and gives the<br />

perfect fit, he says. “The advantage of using the hinge system, compared<br />

to a screw, is that the temples flex and do not loosen, even after a while;<br />

which is something regular frames with screws do.”<br />

Excluding plastic frames, C-Zone represents everything Kiwis look for<br />

in an optical frame, says David Bearpark, director of C-Zone distributor,<br />

Little Peach. “The brand has significant depth in both women’s and<br />

men’s styles. There are stunning colours, innovative designs and a<br />

quality that represents fantastic value for money.<br />

“When all is said and done, Kiwis are looking for more value for their<br />

hard-earned dollars. Add to this a new, clever and affordable technical<br />

aspect, like this new hinge technology, and we confidently expect<br />

C-Zone to continue its remarkable growth in this market.”<br />

For more, see the ad on p3. ▀<br />

sunglasses and optical frames and comes in a range<br />

of sugary colours combined with copper, gold or silver<br />

metal frames. Distributed by Luxottica.<br />

Lindsay – Tort Eggshell by Kate Sylvester:<br />

These beautiful frames are everything<br />

glasses should be – comfortable to wear,<br />

stylish and able to go from day to night<br />

without a drama.<br />

Narrows Mandy: The Narrows Mandy frames<br />

are lightweight, yet durable and while a<br />

simple design in front, the sides allow for<br />

displaying your sense of style and creativity<br />

Ono Cute: The Ono Cute OC110 in brown<br />

makes a lovely change from typical metallic<br />

or black frames. Part of the Ono Children’s<br />

range, they are perfect for a smaller face.<br />

Zeffer Titanium: The Zeffer Titanium 7008<br />

created using pure titanium and hard density<br />

cellulose acetate are incredibly lightweight<br />

and comfortable frames. ▀<br />

Stars and their Eyes …<br />

David Bowie<br />

The late David Bowie’s eyes appeared<br />

heterochromic, however he actually had<br />

anisocoria due to an injury. At age 14, Bowie<br />

and his life-long friend, artist George Underwood,<br />

were both seeking the affection of the same girl,<br />

which ended in a competitive scrap and Underwood<br />

punching Bowie in the eye with a ring-clad fist. The<br />

trauma to his left iris resulted in a fixed, dilated pupil.<br />

But this asymmetry added to Bowie’s mystique, with<br />

many describing his eyes as his most iconic feature.<br />

Years later, Underwood commented, “I’m proud to be<br />

his friend. And as for that accidental punch…Neither of<br />

us knew then that I’d actually done him favour.” ▀<br />

24 NEW ZEALAND OPTICS <strong>Aug</strong>ust <strong>2017</strong>

Eye care on the Cooks<br />

A<br />

team of several New Zealand eye health<br />

professionals completed more than 1200<br />

eye exams, including 250 diabetic patient<br />

examinations; undertook 70 cataract operations;<br />

treated more than 20 diabetic retinopathy cases;<br />

and fitted more than 700 prescription spectacles<br />

in the Cook Islands, in the middle of this year as<br />

part of the annual New Zealand Aid Eye Care Team<br />

programme.<br />

The surgery team was once again led by Auckland<br />

Eye’s Dr Paul Rosser who, along with the other eye<br />

care professionals in the team, has been giving<br />

up his leave to help the aid initiative for nearly 25<br />

years. But this year’s targets nearly weren’t achieved<br />

after Dr Rosser’s bags, including his surgical bag,<br />

were taken off his Jetstar aircraft in Auckland, just<br />

two days before he was due to start surgery.<br />

“The only bit of communication when we arrived<br />

was a thing on the luggage conveyor belt – a little<br />

block of wood – coming around saying: ‘If you have<br />

not got your luggage by now, contact your travel<br />

provider because it has been offloaded’,” Dr Rosser<br />

told the NZ Herald. “I explained that I was a surgeon<br />

going up to do eye surgery for the people who only<br />

get me once a year.”<br />

Passengers’ bags had been removed because<br />

of weight issues and the need to carry more fuel,<br />

Jetstar said. But realising how important Dr Rosser’s<br />

bags were, Jetstar staff flew his bags out to him<br />

two days later, while other passengers had to wait a<br />

further 24 hours for their bags.<br />

Accompanying Dr Rosser on this year’s trip was<br />

Auckland Eye colleagues, Dr Jo Sims and Dr Alison<br />

Dr Shenton Chew, now at Auckland Eye<br />

Pereira, who have been helping<br />

with the Cook Islands eye care<br />

aid initiative for 14 years and<br />

16 years respectively. Other<br />

team members included<br />

Christchurch optometrist and<br />

low vision expert John Veale,<br />

who has been helping for more<br />

than 30 years; fellow low vision<br />

optometrist Theresa Slatten,<br />

two years; ophthalmology and<br />

diabetic nurse Olga Brochner,<br />

a 14-year veteran; therapeutic<br />

optometrist Richard Johnson,<br />

12 years; medical technician<br />

Andre Smith; and Treve<br />

Dromgool, a specialist<br />

diabetic nurse and medical<br />

photographer. The team was<br />

aided by a number of local<br />

eye health and medical specialists including local<br />

ophthalmologist Dr Te Ariki Faireka, ophthalmic<br />

nurse Doris Taripo and “nurse coordinator supreme”<br />

Rangi Tairi, who organises everything and is “a very<br />

special person, says Veale.<br />

Known locally as “Papa John” and an honorary<br />

permanent resident of the Cook Islands because of<br />

his long service to the local population, Veale says<br />

the annual New Zealand Aid trip is an important<br />

initiative not just for Cook Islanders, but also for<br />

New Zealand. It allows Cook Islanders to be treated<br />

at home and saves New Zealand the cost of bringing<br />

them to New Zealand for treatment, he says. “Cook<br />

Dr Paul Rosser and his theatre team at the Rarotonga Hospital Theresa Slatten, John Veale, Rangi Tairei and Richard Johnson Olga Brochner (back) and Dr Pereira with a patient<br />

Auckland Eye’s latest recruit<br />

Glaucoma specialist, Dr Shenton Chew has<br />

joined the team at Auckland Eye. “The<br />

shareholders of Auckland Eye are delighted<br />

Shenton is joining our subspecialty practice, offering<br />

expertise in glaucoma, after recently returning from<br />

a fellowship at Moorfields Hospital in London,” said<br />

Auckland Eye’s Dr Stephen Best.<br />

Dr Chew will continue to deliver ophthalmic care<br />

through the Auckland public hospitals and his role<br />

as spokesperson for the Royal Australian and New<br />

Zealand College of Ophthalmologists. But says<br />

he’s looking forward to working as part of a team<br />

again. “The public system can sometimes feel a<br />

little impersonal due to the sheer size of the service,<br />

whereas Auckland Eye prides itself on its team and<br />

patient-centred approach… (so) I’m excited about<br />

joining the team.”<br />

Dr Chew’s passion is glaucoma and curing and<br />

preventing blindness, he says. “The severity of<br />

Some much-needed R&R for some of the NZ Aid Eye Care Team including Dr Alison Pereira (with her<br />

very large fish) Richard Johnson (back) and, holding the other fish, John Veale and Theresa Slatten<br />

Islanders have New Zealand passports so they are<br />

entitled to New Zealand medical services. So the<br />

whole aim is to reduce the referrals to New Zealand<br />

and treat people in their home country so they also<br />

have the family support they need.”<br />

The New Zealand Aid Eye Care Team evolved from<br />

an initiative started in 1969 by retired Whanganuibased<br />

optometrist Mike Webber, who became<br />

concerned by the number of Cook Islanders who<br />

were suffering eye conditions that if left untreated<br />

would lead to blindness. Dr Paul Rosser was also<br />

awarded honorary Cook Island residency for all his<br />

work in the South Pacific nation in 2012. ▀<br />

glaucoma varies greatly between patients, as does the<br />

age of onset. So, the balance between over and under<br />

treatment on quality of life and visual impairment<br />

needs to be carefully considered.<br />

“I thoroughly enjoy my work. Sight is a sense we<br />

can take for granted and being able to preserve and<br />

improve this for someone is quite something.”<br />

During his two-year glaucoma fellowship at<br />

Moorfields, Dr Chew covered glaucoma and cataract<br />

surgical techniques, including the expanding field of<br />

minimally-invasive glaucoma surgery (MIGS), using<br />

devices such as the iStent, Hydrus, Xen and Cypass,<br />

and the most current trabeculectomy and tube<br />

shunt techniques. He’s an honorary senior lecturer at<br />

Auckland University and has won several prizes and<br />

scholarships, which helped him and his wife, Nola,<br />

survive their two-year stint in London. The couple now<br />

have a young son, Callum, who Dr Chew says keeps<br />

them on their toes. ▀<br />

Optom skills<br />

still wanted<br />

Optometry still on NZ’s skilled migrant wishlist<br />

Despite some intense lobbying about the<br />

potential future oversupply of optometrists<br />

in Australia, optometry remained firmly on<br />

the newly updated skilled-occupation list for fast<br />

track immigration approval in Australia.<br />

On the announcement that optometry would<br />

remain on the newly-named Temporary Skill<br />

Shortage visa list in Australia, governing body<br />

Optometry Australia’s national manager Skye<br />

Cappuccio said, “We are disapointed that optometry<br />

remains on the list of professions for the new<br />

temporary skill shortage visa. Our evidence shows<br />

that there are sufficient optometrists in Australia to<br />

meet the demand for eye care.”<br />

In New Zealand, optometry also remains as<br />

one of the occupations on our immigration skill<br />

shortage list, although it does not appear on the<br />

‘immediate’ or ‘long-term’ shortage lists.<br />

“The government uses robust criteria for the<br />

inclusion and exclusion of occupations on the<br />

skill shortage list and gives preference to wellqualified<br />

immigrants,” said Dr Lesley Frederikson,<br />

national director of the New Zealand Association<br />

of Optometrists (NZAO). “As an association, we do<br />

not see any evidence of a shortage of optometrists<br />

in New Zealand or of a shortage of graduates<br />

coming onto the job market.”<br />

In 2010, there was an eye health workforce<br />

service forecast that concluded there were<br />

‘adequate’ numbers of optometrists in New<br />

Zealand, but their role needs to be expanded in<br />

managing eye health to meet demands. Since this<br />

forecast was completed, changes to the Medicines<br />

Act 1981 now allow optometrists to be authorised<br />

prescribers and diagnose and manage glaucoma in<br />

the community and prescribe medication.<br />

The population of New Zealand is unevenly<br />

distributed and this means that many services such<br />

as optometry are also unevenly distributed, said Dr<br />

Frederikson. “We have some very small centres in<br />

rural areas which do not have a population large<br />

enough to sustain local services, but in general<br />

access to optometrists is available in all regions.”<br />

Under current immigration guidelines, if a<br />

person holds a relevant and recognised optometry<br />

qualification, has enough points and meets the<br />

requirements then they can apply for a resident visa<br />

under the skilled migrant category, allowing them<br />

to live and work in New Zealand indefinitely. ▀<br />

The sight of a dragonfly<br />

Lens company Younger Optics has launched<br />

a dramatic new marketing campaign for<br />

its leading polarised lens product, Nupolar.<br />

Instead of the normal ‘model and sunglasses’<br />

shots, the campaign features a dragonfly whose<br />

highly-evolved optic system helps in navigation<br />

and reducing the sun’s glare on water.<br />

“The new Nupolar campaign is a bold and<br />

confident campaign, the likes of which hasn’t been<br />

seen before in the industry,” said Craig Johnston,<br />

Younger Optics ANZ sales and marketing manager.<br />

“It’s intriguing, thought provoking and a perfect<br />

fit. The dragonfly is a true ruler of its domain, as<br />

are Nupolar polarised lenses.”<br />

The dragonfly has large compound eyes<br />

containing around 30,000 individual facets and<br />

A dragonfly’s eye, the centre piece of Younger Optics’ latest NuPolar lens<br />

up to five visual opsins. It can perceive the full<br />

campaign<br />

colour spectrum, UV light and light polarisation.<br />

According to the company, Nupolar’s HT Film<br />

standard,” said Johnston.<br />

Technology offers film adhesion with no risk of Nupolar lenses are available from independent<br />

delamination; colour stability, so colours remain laboratories in a large range of materials, designs<br />

true; and eliminates fading of lens colour over and prescriptions, they have 100% UV blockage<br />

time. “Nupolar outperforms other polarised<br />

and are suitable for most frames, including rimless,<br />

prescription lenses and is the accepted global wrap and sports frames. ▀<br />

VSP appoints NZ rep<br />

VSP Australia (formerly General Optical) has<br />

appointed Ryan Williams as its new New<br />

Zealand representative.<br />

Describing himself as a “jack of all trades”,<br />

Williams says he’s spent many years in recruitment<br />

and sales, and DJ’ing in night clubs! He also<br />

used to look after Bollé and Uvex on the safety<br />

side, though this was the extent of his optical<br />

knowledge before joining the VSP team, so<br />

he’s looking forward to meeting the country’s<br />

independent optometrists and dispensing<br />

opticians so he can learn more, he says. “And I’m<br />

really looking forward to being the Nike rep to<br />

complement my 60 pairs of Nikes in my wardrobe,”<br />

he laughs.<br />

VSP Australia’s brands, including Nike, Calvin<br />

Klein, Lacoste, Dragon, MCM, Columbia and<br />

Chloe are distributed in New Zealand by action<br />

sports gear distributor Tritan Imports, which has<br />

distributed VSP’s Dragon sunglass brand for a<br />

number of years. Williams joined the Tritan team<br />

DJ and Nike fan Ryan Williams joins the VSP team<br />

in February, replacing Pablo Hurford. Previously<br />

he worked for Salmat, an ASX-listed marketing Rental, home appliance and furniture rental firm,<br />

services business, in Auckland and ran a Mr<br />

franchise. He will be based in Auckland. ▀<br />

<strong>Aug</strong>ust <strong>2017</strong><br />



Chalkeyes presents…<br />

Slack Times<br />

by<br />

David Slack<br />

As far as I can see...<br />

My mother and father lavished attention on me<br />

as a child, and I wanted for nothing. Except for a<br />

pair of glasses. Somehow, they just kept missing<br />

the clues and I kept missing the ball when it was<br />

thrown right at me.<br />

They would say ‘look at that air force jet, it’s<br />

come from Ohakea,’ and the rest of the family<br />

would look up to the long, long vapour trail and<br />

I would say, ‘where? Where is it? I don’t see it’. I<br />

would hold a book close to my face, sit right at the<br />

front to see the blackboard, and they would say,<br />

‘he loves to learn’.<br />

Finally, when I was seven, they began to<br />

think something might be wrong and made an<br />

appointment.<br />

It’s a clear and vivid memory, my first visit to the<br />

optometrist. Outside it was a sunny afternoon,<br />

inside it was as dark as night. The optometrist<br />

had a kind smile, a warm voice, but most of all,<br />

the room was a spaceship cockpit, red and green<br />

lights, elaborate intricate-looking equipment. And<br />

it was utterly quiet; a cocoon.<br />

He showed me a chart of letters, I recited them.<br />

He adjusted things, I read more letters. At the end<br />

he said, ‘we’ll need to put you in some glasses’.<br />

My mother asked him about a new invention<br />

she had heard of. There were lenses you could<br />

put into the eye itself. Was that possible? ‘Oh’, he<br />

said, ‘they’re made of glass. Dreadful things have<br />

happened to people in car crashes. Fragments of<br />

glass, buried in their eyeballs’.<br />

We were farming folk and it was the 1960s, and<br />

people spoke more frankly then, even in a gentle<br />

warm cocoon. But no harm or trauma done. I was<br />

agog. Glass splinters in the eyeball! Hours and<br />

hours of surgery! My unseeing eyes were wide.<br />

A week later we collect the spectacles, I put<br />

them on, he adjusted them and now I had a pair<br />

of horn-rimmed glasses just like my grandfather’s.<br />

If Pierre Cardin was designing spectacles then, he<br />

wasn’t sending any to Palmerston North.<br />

But I could see! This was just marvellous. Show<br />

me an aeroplane! We piled into the car for home.<br />

‘Surprise, I can see! Surprise, I have glasses just<br />

like Grandad’s’. It was only years later that I<br />

learned my brother, not wanting to hurt my<br />

feelings but alarmed at the horn-rimmed glasses,<br />

asked Mum, ‘do we have to look at him?’<br />

What followed were years of frames of all kinds:<br />

small square ones, big round John Lennon ones;<br />

busting them in the playground again and again;<br />

the milk bottles getting a little thicker each time.<br />

For my 21st, Mum bought me my first pair of<br />

contact lenses, which you would wear for months<br />

and spend all morning searching for in the carpet<br />

if you ever dropped them because they were so<br />

very expensive.<br />

And here I am, nearly forty years later, still<br />

reading the letters off the chart and hoping there<br />

might be a prescription that can make a menu<br />

readable. Each time I go back, the technology<br />

seems to have become a little more formidable.<br />

The first time I saw digital images of my own eye<br />

I thought I was looking at a relief map of Mars.<br />

Always, it’s still<br />

an adventure in<br />

outer space.<br />

But the constant<br />

is the cocoon, and<br />

the comfort of it.<br />

Mostly the news<br />

has been cheerful,<br />

just once or twice,<br />

the moonscape has looked a bit off and I’ve been<br />

sent to the ophthalmologist to get the news that<br />

it’s okay, no need to worry. In those moments of<br />

doubt, you realise just how very truly and deeply<br />

your eyesight matters to you, flawed as it may be.<br />

I managed to spear my eye gardening one<br />

Boxing Day and wound up in the emergency eye<br />

clinic at Greenlane hospital. They were using the<br />

oncology department facilities and so I waited<br />

in an enormous La-Z-Boy, ordinarily used for<br />

chemotherapy, thinking to myself as I watched<br />

clinicians tending to scratched and damaged and<br />

burning eyes, ‘these people are the best’.<br />

That’s what creates the cocoon feeling, I<br />

suppose: the sense that a clinician is taking<br />

time with you to be sure you’re well. And isn’t<br />

that what we crave so much in this cold modern<br />

world? To hear someone tell you they want to be<br />

sure you’re okay and know they mean it?<br />

I’m not one of the those stoic types who won’t<br />

see the doctor, won’t get checked up. I had a heart<br />

attack when I was 27 and I am full of appreciation<br />

and gratitude for health professionals. It’s hugely<br />

reassuring to know that good, capable people are<br />

there to help.<br />

And I’ve never had the chance to say all this to<br />

each and every person who has had me read the<br />

letters on the charts, but: thank you. You have<br />

helped me through a clouded world. And your<br />

cocoon is a comforting place to be. I sincerely<br />

hope no upheaval of this modern world will ever<br />

disturb that. ▀<br />

*David Slack is an<br />

author, radio and TV<br />

commentator. He was<br />

speechwriter for PMs<br />

Geoffrey Palmer and Jim<br />

Bolger, and established the<br />

website speeches.com. His<br />

books ‘Bullshit, Backlash<br />

and Bleeding Hearts’ and<br />

‘Civil War ...and Other<br />

Optimistic Predictions’<br />

explore race relations<br />

and various doomsday<br />

scenarios in NZ. He also<br />

wrote ‘Bullrush’, a social history of the popular game.<br />

This the first of what will be a regular<br />

quarterly column, presented by Chalkeyes.<br />

Educational<br />

evening<br />

Dr Narme Deva one of the speakers at Retina Specialists’ seminar<br />

evenings<br />

Auckland-based Retina Specialists is holding<br />

two education evenings on Monday 4 and<br />

Tuesday 12 September in Parnell.<br />

The evenings will discuss interesting and<br />

complicated retina cases and the Retina Specialists’<br />

team welcome case contributions. The main<br />

speakers will be Dr Rachael Barnes, covering what’s<br />

new in age-related macular degeneration; Associate<br />

Professor Andrea Vincent on understanding and<br />

interpreting fundus autofluorescene in clinical<br />

practice; and Dr Narme Deva, managing the<br />

diabetic patient-injections, laser and more.<br />

For more information, please email practice.<br />

manager@retinaspecialists.co.nz; or simply keep<br />

an eye on your email in-box. ▀<br />



FOR SALE<br />

Want to own your own practice or perhaps add<br />

another to your expanding empire?<br />

Due to recent health challenges expressions of<br />

interest are sought helping an old man retire<br />

after 37 years of practice in East Auckland.<br />

Computerized practice management with<br />

extensive database and easy access premises<br />

with off-street parking. All equipment and<br />

stock required is at hand. Lease as required<br />

Could be run on a part-time basis if necessary.<br />

Flexible take-over.<br />

To discuss this great opportunity, enquire in<br />

confidence in the first incidence by email to<br />

c.earnshaw.optom@gmail.com<br />



AcuityKit has a comprehensive<br />

range of digital eyecharts for<br />

eye-care professionals. Ideal for low vision<br />

and domiciliary work.<br />

Visit our website www.acuitykit.com or email<br />

john@acuitykit.com<br />

Eye tracking race heats up<br />

Apple has bought the German-based tech<br />

company, Sensomotoric Instruments,<br />

which specialises in eye-tracking<br />

technology, essential for effective virtual reality<br />

(VR) and augmented reality (AR) applications.<br />

Founded in 1991, Sensomotoric is best known<br />

for its work with Facebook’s Oculus Rift VR kit and<br />

Redbull’s e-sports lab. Facebook and Google made<br />

similar acquisitions last year as the race to make AR<br />

consumer friendly continues. While in June, Apple<br />

released ARKit, which enables developers to overlay<br />

AR holograms on the real world through their<br />

phones. Apple CEO Tim Cooks said AR might be as<br />

transformative as<br />

the smartphone<br />

itself.<br />

In other<br />

news, Korean<br />

tech company,<br />

Visual Camp<br />

announced<br />

Samsung will<br />

be using its VR<br />

Apple, exploring the AR space<br />

eye-tracking<br />

technology on Samsung’s newly unveiled Exynos<br />

VR head-mounted display. ▀<br />

DREAM OF<br />


At OPSM, we are passionate about opening eyes to<br />

the unseen. Our advanced technology enables us to look<br />

deeper to ensure we give the best care to every customer.<br />

OPSM in New Zealand is looking to expand their Locum<br />

Optometrist network.<br />


As a locum you will be your own boss, you will have<br />

the flexibility to set your own hours and will be exposed<br />

to lots of different patients and locations across New<br />

Zealand all while gaining lots of skills and experience.<br />

We are looking for Optometrists who share our passion, are<br />

willing to learn quickly and want to join our customer focussed<br />

teams in making a difference to how people see the world.<br />


• Great working environment<br />

• Fantastic locum rates $$<br />

• Accommodation and flights<br />

• Latest technology<br />

• Luxury brands<br />

• New friends and having fun<br />


For a chance to be your own boss and part of an amazing<br />

team, contact us for a confidential, no obligation chat.<br />

CONTACT:<br />

Hirdesh Nair<br />

hirdesh.nair@opsm.co.nz or call +64 21 523 282<br />


26 NEW ZEALAND OPTICS <strong>Aug</strong>ust <strong>2017</strong>



ASK US<br />


$150K+ FIFO<br />



With Specsavers New Zealand continuing to grow, our store partners are looking to add to their optometry teams – and can<br />

offer an exceptional, fast-paced working environment with great rates of pay and a clinical support team without peer.<br />

If you are looking to elevate your clinical experience, it’s time we talked about the range of opportunities available to you.<br />

Since launching our first practices in the market in 2008, our New Zealand store<br />

network has expanded to more than 50 stores, with annual sales of over $120 million<br />

recorded last year.<br />

With a growing volume of patients in every clinic, we invest in a great range of ophthalmic<br />

equipment – with a visual fields machine in every store and digital retinal photography<br />

performed on every patient. Combined with a deep commitment to professional<br />

development for our entire professional team, we believe there is no better place to<br />

enhance your clinical knowledge and accelerate your career.<br />

We have a variety of options available, including regular locum roles with your choice<br />

of locations, 40-hour week fly-in fly-out (FIFO) opportunities where accommodation<br />

is provided, as well as permanent positions. We also have opportunities for graduate<br />

optometrists and a structured program that can lead you to partnership if you believe<br />

you’re ready for store ownership.<br />

All these options come with the backing of well-trained in-store clinical support teams<br />

and store partners, who will work with you every step of the way to help you achieve<br />

your career goals – whatever they may be.<br />

Call and ask about our $150,000+ FIFO package and special Wellington and Christchurch opportunities today.<br />

Contact Matthew Cooney on 0800 717 350 / +61 (0)447 276 483 or at matthew.cooney@specsavers.com or<br />

Cindy Marshall on 0800 717 350 / +61 (0)450 609 872 or at cindy.marshall@specsavers.com<br />


Voted by New Zealanders<br />

Reader’s Digest<br />

Quality Service<br />

Award<br />

<strong>2017</strong><br />

Best Talent<br />

Development<br />

Program<br />

<strong>2017</strong><br />

Best Customer<br />

Service in NZ<br />

Optometry<br />

<strong>2017</strong><br />

Millward Brown<br />

Research<br />

No.1 for eye tests<br />

2016<br />

Excellence in<br />

Marketing<br />

Award<br />

2016<br />

Retail<br />

Store Design<br />

Award<br />

2016<br />

Retail<br />

Employer<br />

of the Year<br />

2015<br />

Overall<br />

National<br />

Supreme Winner<br />

2015<br />

Franchise<br />

Innovation<br />

Award<br />

2015<br />

NZ Franchise<br />

System of<br />

the Year<br />

2014<br />

Retail<br />

Innovator<br />

of the Year<br />

2014<br />

<strong>Aug</strong>ust <strong>2017</strong><br />






We are looking for motivated dispensing opticians or experienced<br />

optical assistants who have exceptional customer-service skills. We<br />

are a well established and busy practice in Westfield Albany on the<br />

North Shore of Auckland.<br />

If you strive for excellence, would like to have potential for growth<br />

in your new role and enjoy working in a big friendly team then this<br />

opportunity is for you.<br />

Competitive salary package and generous bonuses for the right<br />

canditate.<br />

To apply, please email your CV and cover letter to:<br />

dir.albany.nz@specsavers.com<br />

Naomi Meltzer BSc, Dip Opt, PostGrad.Dip.Rehab.<br />

Low Vision Optometrist<br />

Ph: (09) 520 5208<br />

0800 555 546<br />

Fax: (09) 520 5515<br />

PO Box 28486<br />

Auckland 1541<br />

info@lowvisionservices.nz<br />

www.lowvisionservices.nz<br />


Specsavers require a full-time Optometrist at<br />

our Nelson store.<br />

Please contact Amanda on 03 5480168 or<br />

dir.nelson.nz@specsavers.com for further information.<br />

low vision<br />

services<br />

Low Vision Consultations available at<br />


An Optometrist dedicated to Low Vision support.<br />


Therapeutically qualified.<br />

Auckland or other regions by negotiation. Please contact Mellissa<br />

Teh on 021 1571136 or hetassillem@gmail.com<br />

For all your optical and ophthalmic needs<br />

nzowa.org.nz<br />



OpticsNZ has been engaged by a private Ophthalmology clinic in<br />

Rockhampton wishing to appoint/employ an Optometrist and/or<br />

Orthoptist, they would consider employing two Optometrists or<br />

two Orthoptists.<br />

Package details are strong, nice warm lifestyle location.<br />

Enquiry welcome from any NZ registered Optometrists or<br />

Orthoptists, by phone (03) 5466-996 or email<br />

stu@opticsnz.co.nz<br />



We are looking for experienced Dispensing Opticians or Optical<br />

Assistants to join our practice in Westcity Henderson Mall.<br />

The suitable candidate must have highly developed<br />

communication skills, interpersonal skills, understand the<br />

importance of the patient experience and work well in a team<br />

environment.<br />

Please forward your CV and cover letter to:<br />

mgr.henderson.nz@specsavers.com<br />



Unique opportunity to acquire long established practice in the busy<br />

Riccarton suburb of Christchurch. The spacious premises are fitted<br />

out to a high specification custom design and have an excellent<br />

high-profile location on Riccarton Road opposite Westfield Mall.<br />

The client base is large, extremely loyal and appreciates the<br />

individual and personal clinical service that the practice offers<br />

alongside high quality optical dispensing. With scope for further<br />

growth this practice offers an exceptional opportunity to practice<br />

your own brand of independent optometry.<br />

For a confidential discussion, including possible finance options,<br />

please email Julia Saulsbury:<br />

js.visoncare@xtra.co.nz<br />



A rare chance to join one of the<br />

South Island’s and Christchurch’s leading independent optometry<br />

practices. Curtis Vision has a proud, long history of providing the<br />

highest quality clinical expertise and delivering tailored product<br />

solutions to its valued patients.<br />

Our ideal candidate will have a minimum of five years’ experience<br />

along with a continuing enthusiasm to learn within a supportive<br />

environment of highly skilled colleagues. Salary and other benefits<br />

to be negotiated, reflecting the quality of the successful candidate.<br />

Please send your CV and covering letter (in complete confidence)<br />

to Shelley Endacott, Practice Manager:<br />

shelley@curtisvision.co.nz<br />


Seeking interest in an optometry-lifestyle opportunity in Central<br />

Otago. Part-time role with opportunity to expand for the right<br />

person. The role suits outgoing, motivated, very thorough<br />

therapeutic optometrist for medical based practice.<br />

Submit interest to myamazingnewjob@gmail.com<br />



At OPSM, we are passionate about opening eyes to<br />

the unseen. Our advanced technology enables us to look<br />

deeper to ensure we give the best care to every customer.<br />




We are looking for Optometrists who share our passion<br />

and want to make a difference to how people see the<br />

world. Whether you like the city, the surf or the outback,<br />

we’ve got the role for you with our teams in:<br />

• Bundaberg<br />

• Cairns<br />

• Darwin<br />

• Katherine<br />

• Mackay<br />

• Mt Isa<br />

• Toowoomba<br />

• Townsville<br />


You can look to take on a fixed period role or even<br />

consider a more permanent move – who knows,<br />

you might fall in love with the place. Depending on<br />

the location, salary packages up to 175K including<br />

superannuation, accommodation, annual return<br />

flights to visit family and friends and relocation<br />

support for the right candidate. Start your journey<br />

with us today! Graduates or recent graduates<br />

are very welcome to apply.<br />

CONTACT:<br />

Brendan Philp<br />

brendan.philp@luxottica.com.au or call +61 418 845 197<br />

Kim Shepherd<br />

kim.shepherd@opsm.com.au or call +61 408 763 575<br />




At OPSM, we are passionate about opening eyes to<br />

the unseen. Our advanced technology enables us to look<br />

deeper to ensure we give the best care to every customer.<br />



Our New Zealand business is looking for passionate<br />

Optometrists to join the team.<br />

• Bayfair, Tauranga<br />

• Thames, Thames-Coromandel<br />

• The Plaza, Palmerston North<br />

• Willis St, Wellington<br />

• Queensgate, Wellington<br />

• The Crossings, Christchurch<br />

• Dunedin, Otago<br />

• Wellington float, Wellington Region<br />

When you join OPSM, you work within a team who<br />

are committed to providing the best possible eyecare<br />

solution with exceptional customer service. You will work<br />

with world class technology including our exclusive<br />

Optos Daytona ultrawide digital retina scanner. You<br />

will have many opportunities for continuing professional<br />

development and can enjoy career flexibility through<br />

our extensive store network. You can also make a<br />

real difference in the way people see the world by<br />

participating in our OneSight outreach program.<br />


Start your journey with us today!<br />

Recent graduates are very welcome to apply.<br />

CONTACT:<br />

Hirdesh Nair<br />

hirdesh.nair@opsm.co.nz or call +64 21 523 282<br />


LX21_OPSM_NZOpticsAU_Advert_2.indd 1<br />

28 NEW ZEALAND OPTICS <strong>Aug</strong>ust <strong>2017</strong><br />

21/3/17 11:14 am

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!